Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
   volgende >>
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             1155 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abstract converted to O-09.
76-77 S p. S38
artikel
2 Abstract converted to O-26.
76-77 S p. S56
artikel
3 Abstract converted to P-85
76-77 S p. S11
artikel
4 ABSTRACT REVIEWERS
76-77 S p. iii
artikel
5 ABSTRACT REVIEWERS
76-77 S p. ii
artikel
6 ABSTRACT REVIEWERS
76-77 S p.
artikel
7 Abstract withdrawn.
76-77 S p. S53
artikel
8 Abstract withdrawn.
76-77 S p. S38
artikel
9 Abstract withdrawn.
76-77 S p. S47
artikel
10 Abstract withdrawn.
76-77 S p. S61
artikel
11 Abstract withdrawn.
76-77 S p. S61
artikel
12 Accelerator-produced actinium-225 under the US DOE Tri-Lab collaboration: 2022 update Burgoyne, Andrew

76-77 S p. S42-S43
artikel
13 Accelerator production of 71As from metal germanium targets Lo, Yi-Hsuan

76-77 S p.
artikel
14 Access to 18F-labeled FAP inhibitor variants via [18F]SuFEx reaction Kogler, Jürgen

76-77 S p. S16
artikel
15 227Ac Content in Tri-Lab Accelerator-Produced 225Ac: 2023 Update Burgoyne, Andrew

76-77 S p.
artikel
16 225Ac labeled anti-HER2 2Rs15d sdAb as a potential therapeutic for targeted alpha therapy – an in vitro and in vivo evaluation Rodak, Magdalena

76-77 S p. S33
artikel
17 A clickable C-glycosyl scaffold for RGD peptide dimer labelling and application in bimodal [18F]PET/NIRF imaging Jouad, Kamal

76-77 S p. S42
artikel
18 A Comparison of Cation Exchange and Extraction Resin Column-based Chromatography Methods for Isolating MURR Produced 161Tb Bokolo, Patrick

76-77 S p.
artikel
19 A comparison of rhenium isolation and tungsten recovery methods from bulk tungsten targets Charles, Anster

76-77 S p. S104
artikel
20 A convenient tritiation strategy for tetrazines Bidesi, Natasha

76-77 S p. S90
artikel
21 Actinium-225 labeling of DOTATATE and DOTA-JR11 for the treatment of SSTR2-positive tumors Handula, Maryana

76-77 S p. S191
artikel
22 Advances in the automation technologies within LARAMED project Martini, Petra

76-77 S p. S21
artikel
23 A facile 18F radiochemistry of making (-)-[18F]TZ8024 for imaging VAChT and initial metabolite analysis in rat plasma and brain Zhao, Haiyang

76-77 S p. S39
artikel
24 A facile radiosynthesis of [18F]FBA-Pep42, a cyclic peptide targeting glucose-regulated protein 78 (GRP78) Yang, Hao

76-77 S p. S72
artikel
25 A facile synthesis of beta-amyloid PET imaging agent [18F]Florbetaben Akula, Hari

76-77 S p. S85
artikel
26 A fluorescent probe as a lead compound for a potential α-syn PET tracer: design and development of a library of RB1 derivatives Di Nanni, Adriana

76-77 S p. S94
artikel
27 A fluorescent probe as a lead compound for a selective α-synuclein PET tracer: development of a library of 2-styrylbenzothiazoles and biological evaluation of [18F]PFSB and [18F]MFSB Di Nanni, Adriana

76-77 S p.
artikel
28 A 68Ga-labeled linear peptide-based PET radiotracers for imaging PD-L1 status in tumors Hu, Kuan

76-77 S p.
artikel
29 A kit-based approach to aluminium-[18F]fluoride-labelled microbubbles and their in vivo biodistribution following ultrasound-targeted microbubble destruction Teh, Jin Hui

76-77 S p.
artikel
30 Albumin binders: a potential strategy for enhanced treatment of NETs using SSTR2 antagonists Koustoulidou, Sofia

76-77 S p. S191-S192
artikel
31 Al18F-Radiolabeling of PSMA-11 in a media of protic ionic liquids Antuganov, Dmitrii

76-77 S p. S76-S77
artikel
32 ALISI – automated light-induced synthesis of 89Zr-labelled antibodies for immuno-PET Klingler, Simon

76-77 S p. S5-S6
artikel
33 Alpha particle therapy for the treatment of metastatic tumors of prostate cancer Bidkar, Anil

76-77 S p.
artikel
34 Alternate radiohalogens for trametinib PET imaging Pratt, Edwin

76-77 S p. S52
artikel
35 Alternative protective group strategy for the radiosynthesis of Flortaucipir 18F Xiong, Hui

76-77 S p. S88
artikel
36 A 177Lu-labeled anti-HER2 dual variable domain antibody MacPherson, Douglas

76-77 S p. S9
artikel
37 A multi-modality platform employing supramolecular chemistry to radiolabel antibodies d’Orchymont, Faustine

76-77 S p. S27-S28
artikel
38 A multimodal SPECT: photoacoustic imaging agent for bacterial infection Swann, Rowan

76-77 S p. S62-S63
artikel
39 Analysis beyond the image, new prospects in α autoradiography Donnard, Jerome

76-77 S p.
artikel
40 Analysis of radiochemical stability and in vivo distribution of recoiled 213Bi from [225Ac]Ac-DOTATATE in preclinical model Dijie, Liu

76-77 S p.
artikel
41 An approach towards reverse generator system for 99mTc separation from LSA 99Mo Cieszykowska, Izabela

76-77 S p. S97
artikel
42 An effective process for radiolabelling of bioactive amines from 2,2-difluoro-2-[18F]Fluoro-ethyl 4-methylbenzenesulfonate, a versatile tool for 18F-radiotracer development Maqbool, Mudasir

76-77 S p. S82
artikel
43 An Evaluation of the Production of High Specific Activity 155Tb via Alpha-Irradiation of Thick Natural Eu2O3 and Enriched [153Eu] Eu2O3 Targets Charles, Anster

76-77 S p.
artikel
44 A new in silico approach to revolutionize CNS PET tracer design and enhance translational success Jackson, Isaac

76-77 S p. S24-S25
artikel
45 A new paradigm of cancer immunotherapy based on [18F]FDG and anti-PD-L1 mAb combination Wen, Xuejun

76-77 S p. S219-S220
artikel
46 A new phenylstannyl precursor for synthesizing [11C]UCB-J Mori, Wakana

76-77 S p.
artikel
47 A new prospective CB2 receptor tracer based on a 18F labelled naphthyridine core: radiosynthesis and microPET imaging data Pascali, Giancarlo

76-77 S p. S35
artikel
48 A new rhenium/technetium-99m complex bearing a quinazoline derivative and 2-picolylamine-N-acetic acid for EGFR imaging Makrypidi, Konstantina

76-77 S p. S15
artikel
49 An improved separation scheme for 44Sc purification from proton irradiated calcium Kurakina, Elena

76-77 S p. S92
artikel
50 An improved synthesis of [18F]VAT precursor for a one-step radiofluorination Hu, Bao

76-77 S p. S85-S86
artikel
51 An interleukin-2 derived small peptide probe for CD25 targeted PET/CT imaging of activated T cells Wang, Shuailiang

76-77 S p. S7
artikel
52 An orthogonal labeling strategy to accelerate bioconjugation of [99mTc]Tc-building blocks Braband, Henrik

76-77 S p. S32-S33
artikel
53 A novel building block facilitates the synthesis of the 89Zr-Chelator DFO* Feiner, Irene

76-77 S p.
artikel
54 A novel 18F-labeled reversible PET ligand for imaging monoacylglycerol lipase Rong, Jian

76-77 S p.
artikel
55 A novel flexible pipetting-based platform for automated microvolume radiochemistry Lu, Yingqing

76-77 S p. S58-S59
artikel
56 A novel fluorine-18 labeled P2Y12 receptor PET tracer for imaging of anti-inflammatory microglia van der Wildt, Berend

76-77 S p. S108-S109
artikel
57 A novel PET ligand for imaging monoacylglycerol lipase in naïve and mouse models of Alzheimer’s disease Rong, Jian

76-77 S p. S21
artikel
58 A Novel Prosthetic group, 4-[18F]Fluorophenylglyoxal for Protein Conjugation Sadasivam, Pragalath

76-77 S p.
artikel
59 A Novel Purification Method to Improve the Chemical Purity of the 203Pb/212Pb Theranostic Pair McNeil, Brooke

76-77 S p.
artikel
60 A novel radioiodinated probe for diagnosis of systemic amyloidosis based on thioflavin-T and Congo-red hybrid structure Haratake, Yoshie

76-77 S p. S54-S55
artikel
61 A novel radioiodination method for the preparation of radiopharmaceuticals Debnath, Shuvra

76-77 S p.
artikel
62 A novel radiotracer for imaging autotaxin: [18F]THPDPATX Ebrahimi, Edris

76-77 S p. S186
artikel
63 A novel synthesis of [11C]FTIMD Ishii, Hideki

76-77 S p.
artikel
64 A novel tetrahydrothienopyridine-based PET tracer for P2Y12 receptor imaging in the brain Joseph, Emanuel

76-77 S p. S47
artikel
65 Antibody-based PET imaging of alpha-synuclein Syvaenen, Stina

76-77 S p.
artikel
66 Antibody-based radioligands can distinguish between amyloid-beta subtypes beyond [11C]PiB-positive pathology Syvaenen, Stina

76-77 S p.
artikel
67 Anti-EphA2 Minibody as a targeting antibody for the molecular imaging of fibrosarcoma tumors. Birikorang, Peggy

76-77 S p.
artikel
68 Antigen-dependent inducible T cell reporter system for PET imaging of tumor specific antigens Shin, Jaehoon

76-77 S p.
artikel
69 Antimicrobial peptide form native plant Erythrina crista-galli: a promising agent for diagnostic of infection foci Osorio, Jessica

76-77 S p. S72-S73
artikel
70 A pilot study of [18F]AlF-HER2 Affibody in HER2-positive breast cancer patients Guo, Xiaoyi

76-77 S p. S49
artikel
71 Application of ionic liquids for ring-opening of non-activated aziridines with [11C]CO2 Lindberg, Anton

76-77 S p. S28-S29
artikel
72 Application of Machine Learning Driven Computational Approaches for Novel CNS PET Tracer Development Jackson, Isaac

76-77 S p.
artikel
73 Application of quaternary 1,4-diazabicyclo[2.2.2]octan (DABCO) salts for SN2 “minimalist” radiofluorination Keuthen, Yannick

76-77 S p. S49
artikel
74 A Practical Production of Clinical Interesting Radiotracer [11C]UCB-J Akula, Hari

76-77 S p.
artikel
75 Apramer-based synthesis of radiopharmaceuticals Belugin, Kirill

76-77 S p. S179
artikel
76 A preclinical platform for the radiolabelling and in vivo monitoring of nanoparticles against Crohn’s Disease using live dynamic SPECT imaging Karampelas, Theodoros

76-77 S p. S54-S55
artikel
77 A Preclinical Platform to Thoroughly Evaluate Novel Nanocomposites in the Full Spectrum of Drug Discovery (in vitro - in vivo - ex vivo) Towards Cancer Treatment Sarpaki, Sophia

76-77 S p.
artikel
78 A Preliminary Study of the Ortho Effect on Radiofluorinations Using Aryl Sulfonium Salt Precursors Zhang, Wei

76-77 S p.
artikel
79 A pretargeting approach to PET imaging with antibodies Penawou, Pamela

76-77 S p. S59-S60
artikel
80 A pyrene-phthalocyanine conjugate for dual Cherenkov radiation-induced near-infrared luminescence imaging and photodynamic therapy lioret, Vivian

76-77 S p. S105-S106
artikel
81 A quest for simplicity: automated cassette-based purification of [61Cu]CuCl2 from solid Ni targets using a single time-list Svedjehed, Johan

76-77 S p. S170
artikel
82 A rapid non-radiometric LC-MS/MS procedure for measuring the molar activity of cyclotron-produced [18F]fluoride Ellin, Nicholas

76-77 S p.
artikel
83 Aryliodonium ylides as efficient precursors for astatine-211 labeling Maingueneau, Clémence

76-77 S p. S174-S175
artikel
84 Arylpalladium complexes on solid supports for convenient last-step labelling of bioconjugates by [11C]CO Hermange, Philippe

76-77 S p. S72
artikel
85 A side-by-side comparison of a monomer- versus a dimer-based 68Ga- and 177Lu-labeled FAP inhibitor for theranostic tumor stroma targeting Läppchen, Tilman

76-77 S p.
artikel
86 A simple and fully automatic production of [18F]SMBT-1 using an All-in-One chemistry module Ko, Nare

76-77 S p.
artikel
87 A simplified radiosynthesis of [18F]FMPEP for imaging CB1 receptors Pees, Anna

76-77 S p. S83
artikel
88 A single-pot photo-induced reaction for zirconium-89 radioimmunoPET agents: an efficient approach for translation of radiolabeled antibodies for human use Fong, Cyril

76-77 S p. S119-S120
artikel
89 Assessing the binding affinity of a 64Cu-labeled PSMA ligand in a micro physiological system Sihver, Wiebke

76-77 S p.
artikel
90 Assessment for anti-fatigue effect of traditional oriental medicine via PET/CT Park, Sun Mi

76-77 S p.
artikel
91 Assessment of [64Cu]Cu-FAP-2286 in immunocompetent mice bearing pancreatic ductal adenocarcinoma (PDAC) tumors Seo, Jai Woong

76-77 S p.
artikel
92 Assessment of novel mesothelin specific human antibody VH-Fc fusion proteins-based PET agents Cortez, Angel

76-77 S p.
artikel
93 Assessment of the influence of [18F]florastamin isomer on pharmacokinetic properties for prostate cancer diagnosis: preclinical comparison of biodistribution Lee, Kyongkyu

76-77 S p.
artikel
94 A stable and robust production process of [18F]fluorodeprenyl-D2 using a cassette-type chemistry module Ko, Nare

76-77 S p.
artikel
95 Astatine-211 based PSMA-inhibitors for targeted alpha-therapy of prostate cancer Poulie, Christian

76-77 S p. S60
artikel
96 A structure-activity relationship study of bimodal BODIPY-labeled PSMA-targeting bioconjugates Stemler, Tobias

76-77 S p. S26-S27
artikel
97 A study to obtain a highly reproducible radiochemical yield (RCY) in the PSMA-11 radiolabeling Iudicello, Antonella

76-77 S p. S142-S143
artikel
98 At-211-labeled L-tyrosine derivatives via neopentyl scaffold for targeted α-therapy Kaizuka, Yuta

76-77 S p. S12-S13
artikel
99 A trifluoroborate (BF3) radioprosthetic group bearing FAP-targeting ligand for facile labeling with 18F via the 18F-19F isotope exchange reaction: synthesis, radiolabeling and in vivo evaluation Bendre, Shreya

76-77 S p. S179-S180
artikel
100 Auger electrons in radionuclide therapy: Szilárd-Chalmers effect/hot atom chemistry during the targeted delivery of the isotopes Szucs, Zoltán

76-77 S p.
artikel
101 Au@Pt core-shell nanoparticle bioconjugates for Auger electron radiotherapy – preliminary studies Wawrowicz, Kamil

76-77 S p. S82-S83
artikel
102 Author Index
76-77 S p. S223-S235
artikel
103 AUTHOR INDEX
76-77 S p. S76-S81
artikel
104 Author Index
76-77 S p. S109-S114
artikel
105 Author Index
76-77 S p.
artikel
106 Automated cassette based synthesis of novel CB1 receptor tracer [18F]FPATPP produced via Ru-mediated 18F-fluorination Rajala, Noora

76-77 S p.
artikel
107 Automated Clinical Radiosynthesis of [18F]-F-AraG using the Elixys FLEX/CHEM and PURE/FORM Synthesis System Deyerle, Phillip

76-77 S p.
artikel
108 Automated 18F-Al-radiolabelling optimization of PSMA-11 for PET imaging using a design of experiments approach Wagner, Laurène

76-77 S p. S138-S139
artikel
109 Automated multidoses production of [68Ga]PentixaFor in general purpose commercial module and its preclinical evaluation in lymphoma model Sahu, Sudeep

76-77 S p. S211
artikel
110 Automated One-pot and One-step Radiosynthesis of [18F]VAT for PET Imaging of Vesicular Acetylcholine Transporter Tu, Zhude

76-77 S p.
artikel
111 Automated production of [18F]AldoView: first translation of a sulfonium salt precursor to GMP Sirindil, Fatih

76-77 S p. S137
artikel
112 Automated production of sodium [11C]butyrate Pakula, Ryan

76-77 S p. S70-S71
artikel
113 Automated purification of 18F-compounds by semi-preparative supercritical fluid chromatography (SFC) Maindron, Nicolas

76-77 S p. S22-S23
artikel
114 Automated purification of radiometals produced by solid targets Gongora-Servin, Benito

76-77 S p.
artikel
115 Automated radiolabeling of [68Ga]Ga-DOTATOC using the iMiDEV™ automated microfluidic radiosynthesizer Chandrashekara, Hemantha Kumara

76-77 S p. S122-S123
artikel
116 Automated radiosyntheses of [18F]FMPEP-d 2 and [18F]MAGL-2102 for imaging the endocannabinoid system Pees, Anna

76-77 S p.
artikel
117 Automated radiosynthesis of [18F]AlF-FAPI-42 Gröner, Benedikt

76-77 S p. S61-S62
artikel
118 Automated radiosynthesis of [18F]AV-45 using Elixys FLEX/CHEM and PURE/FORM synthesis system Miller, William

76-77 S p. S132
artikel
119 Automated radiosynthesis of [18F]DOPA and [18F]FMT via copper-mediated nucleophilic F-18 Fluorination of arylstannanes on a new synthesizer Nagachinta, Surasa

76-77 S p. S133-S134
artikel
120 Automated radiosynthesis of 6-[18F]F-L-DOPA from a boronic precursor on NEPTIS® module Maindron, Nicolas

76-77 S p. S129
artikel
121 Automated radiosynthesis of [18F]FMeNER-D2 using the simplified one-pot 18F-fluoromethylation. Zhang, Ming-Rong

76-77 S p.
artikel
122 Automated radiosynthesis of meta-[18F]Fluorobenzylguanidine from a diaryliodonium salt precursor on NEPTIS® module Maindron, Nicolas

76-77 S p. S131
artikel
123 AUTOmated radiosynthesis of para-[131I]Iodo-L-phenylalanine on NEPTIS® module Maindron, Nicolas

76-77 S p. S130-S131
artikel
124 Automated radiosynthesis of the 18F-labeled BF2-chelated tetraaryl-azadipyrromethenes photosensitizer using isotopic exchange Kawamura, Kazunori

76-77 S p. S81-S82
artikel
125 Automated synthesis and quality control of [18F]FFNP with GMP compliance Kim, Dong Hyun

76-77 S p. S127-S128
artikel
126 Automated synthesis of D-[3-11C]Alanine on the Sofie Biosciences Elixys Flex/Chem Simpson, Spenser

76-77 S p. S136-S137
artikel
127 Automated synthesis of 16-[131I]iodohexadecanoic acid: a lymphatic leakage tracer Plhak, Elisabeth

76-77 S p. S59-S60
artikel
128 Automation of 4-[18F]fluorogabapentin radiosynthesis Zhou, Yu-Peng

76-77 S p. S66
artikel
129 Automation of two-step one-vessel ditosylate synthon fluorination using Trasis AllinOne Lee, Hsiaoju

76-77 S p.
artikel
130 Automation of two-step synthesis of [18F]FP-TMP using Trasis AllinOne Lee, Hsiaoju

76-77 S p. S127
artikel
131 A versatile cassette-based adaptor for solid targets dissolution on commercial synthesis modules Sciacca, Gabriele

76-77 S p. S46-S47
artikel
132 3-Aza-6-[18F]fluoro-isatoic anhydrides ([18F]AFIAs) - novel prosthetic groups for indirect radiolabeling Willmann, Michael

76-77 S p. S28
artikel
133 131Ba as a promising SPECT-diagnostic match for 223/224Radium Reissig, Falco

76-77 S p. S95
artikel
134 Behind the scenes of Ga-68-Trivehexin development: unique structure-activity relationships Quigley, Neil

76-77 S p. S208-S209
artikel
135 8-Bicycloalkyl-CPFPX derivatives as potent and selective tools for PET imaging of the A1 adenosine receptor Holschbach, Marcus

76-77 S p. S26-S27
artikel
136 Bifunctional [2.2.2]-cryptands: Selective and efficient chelators for the 203Pb/212Pb theranostic pair McDonagh, Anthony

76-77 S p.
artikel
137 Binding of [64Cu]DOTATATE beyond the BBB Andersen, Ida

76-77 S p. S172-S173
artikel
138 Bioconjugates labeled with Auger electron emitter: 135La, as potential therapeutic radiopharmaceutical Walczak, Rafał

76-77 S p. S159
artikel
139 Bioconjugates of 103Pd/103mRh in-vivo generator for targeted Auger electron therapy Gieraltowska, Joanna

76-77 S p. S188-S189
artikel
140 Biodistribution of a 67Ga-labeled anti-TNF VHH single-domain antibody containing a bacterial albumin-binding domain (Zag) Morais, Maurício
2014
76-77 S p. e44-e48
nvt p.
artikel
141 Biodistribution of [89Zr]DFO-Maleimide-VLP-1 in Wistar Rats by Positron Emission Tomography (PET) Riffel, Kerry

76-77 S p.
artikel
142 Biological evaluation of [18F]FDG-Tz as a tracer candidate for pretargeted PET imaging Auchynnikava, Tatsiana

76-77 S p. S71-S72
artikel
143 Biological evaluation of 111In-clickable complexes for cancer theranostics D’Onofrio, Alice

76-77 S p. S188
artikel
144 Bioorthogonal chemistry approach for theranostics of GRPR-expressing cancers Gano, Lurdes

76-77 S p. S30
artikel
145 2,6-Bis-(N-hydroxylamino)-1,3,5-triazines as ligands for 45Ti-chelation Hoffmann, Chris

76-77 S p.
artikel
146 Bispecific antibody-based radiopharmaceutical towards phosphorylated TDP-43 Pakula, Ryan

76-77 S p. S103
artikel
147 Bispidine - One chelator to bind lutetium-177 and actinium-225 Brühlmann, Santiago

76-77 S p.
artikel
148 Bispidin-9-ol derivatives for copper-64:67 radiolabeling and facile biofunctionalization strategies Wünsche, Adrian

76-77 S p. S74-S75
artikel
149 Blood–brain barrier penetrating peptide-based radioligands targeting the EGFR:EGFRvIII receptors Schuderer, Franziska

76-77 S p. S71-S72
artikel
150 Blood-brain barrier permeable antibodies for brain imaging van den Broek, Sara Lopes

76-77 S p.
artikel
151 Borylation and 18F-Fluorination of arenes mediated by Lewis-acid organocatalysts Garcia, Raul Perez

76-77 S p. S84
artikel
152 Brain energetics by biomedical modalities Tiwari, Anjani

76-77 S p. S108
artikel
153 Bringing personalized medicine to the next level: RANKL immuno-PET imaging using [64Cu]Cu-NOTA-anti-RANKL-Fab fragments Dewulf, Jonatan

76-77 S p. S184-S185
artikel
154 Bucherer-Bergs multicomponent reaction with [11C]CO2, a facile and divergent synthesis of 11C-labelled hydantoins van der Aa, Frank

76-77 S p. S75
artikel
155 Cancer theranostics using radiolabelled PARP inhibitors Ferrat, Mélodie

76-77 S p.
artikel
156 Can the Radiochemical Purity of 225Ac-Labeled Compounds be Accurately Assessed by Radio-TLC Alone? Wacker, Anja

76-77 S p.
artikel
157 Capsular reformulation of the PET radiopharmaceutical [18F]FTHA for oral administration Moerlein, Stephen

76-77 S p. S144
artikel
158 Carbamoyl fluoride as a potential new tag for 18F-labeling Bonnefoy, Clémence

76-77 S p. S77-S78
artikel
159 Carbasugars synthesis and derivatization: a new labelling strategy with 99mTc for infection diagnostic agents Gretter, Mariella Terán

76-77 S p. S40-S41
artikel
160 Carbon-11 carboxylation of trialkoxysilane and trimethylsilane derivatives using [11C]CO2 Bongarzone, Salvatore

76-77 S p. S68
artikel
161 Carbon-11 labelled isocyanides: new versatile building blocks to access novel PET tracers Bonnemaire, Coralie

76-77 S p. S27-S28
artikel
162 Carbon-11 Labelling of Benzenesulfonamide Analogues as Novel Radiotracers to Visualize the Pore-forming Activity of Perforin Zhang, Bo

76-77 S p.
artikel
163 Cationic pH-responsive albumin binding ligands (ABLs) for enhanced cancer-specific theranostics Lee, Jeong-Seob

76-77 S p.
artikel
164 11C-Carbonylation using TracerLab FX Synthesis modules Shao, Xia

76-77 S p. S136
artikel
165 [11C]Carboxylated tetrazines for facile labeling of trans-cyclooctene-functionalized macromolecules Vázquez, Rocío García

76-77 S p. S71-S72
artikel
166 11C-Carboxylation via organic photoredox-catalyzed isotopic exchange Munch, Maxime

76-77 S p. S29
artikel
167 CD46 targeted, Actinium-225 labelled antibody for treatment of prostate cancer xenografts Bidkar, Anil

76-77 S p. S31
artikel
168 CD133-Targeted Radioimmunotherapy of Small Cell Lung Cancer Sebastiano, Joni

76-77 S p.
artikel
169 Cell membrane localization of terbium-161 using peptide receptor antagonists: can we profit from Auger electron emission with non-internalizing targeting agents? Müller, Cristina

76-77 S p. S26
artikel
170 Centralized GMP production of [90Y]Y-PentixaTher for clinical trials Berroteran-Infante, Neydher

76-77 S p. S121
artikel
171 Cerenkov Luminescence Signal Enhancement using Hyperbolic Metamaterials as a Multi-modal Imaging Probe Boykoff, Natalie

76-77 S p.
artikel
172 cGMP synthesis of 4-[18F]fluoro-1-naphthol, a novel PET tracer for imaging activation of innate immunity Pisaneschi, Federica

76-77 S p.
artikel
173 11C-guanylated histamine for PET cardiac imaging Mhanna, Karim

76-77 S p.
artikel
174 C-H activation: optimisation of palladium mediated 11C methylation Ariztia, Julen

76-77 S p. S70
artikel
175 Characterization of a PET radioligand suitable for imaging and quantification of sigma-2 receptor in the primate brain Zheng, Ming-Qiang

76-77 S p. S5
artikel
176 Characterization of new FSHβ-derived peptide probes for the validation of FSHR as a new prognostic and predictive biomarker in primary and metastatic cancers Carpanese, Debora

76-77 S p. S89
artikel
177 Chelation of Manganese - 52 for development of long-lived PET radiopharmaceuticals Omweri, James

76-77 S p.
artikel
178 Chelator-based non-peptidic radiotracers for PET imaging of PD-L1 with copper-64 Krutzek, Fabian

76-77 S p. S38
artikel
179 Chemically Identical Pair of Theranostic Small-Molecule Drug Conjugates for Prostate Cancer Imaging and Chemotherapy Hao, Guiyang

76-77 S p.
artikel
180 Chemoenzymatic Synthesis of Fluorine-18-Labelled Disaccharides Used for PET Imaging of Bacteria Infection Sorlin, Alexandre

76-77 S p.
artikel
181 Cholesterol-depleting drugs for HER2-targeted radioimmunotherapy of patient-derived esophagogastric (EG) cancer Rao, Yi

76-77 S p. S210-S211
artikel
182 Choosing the right molar activity of an 122I-labeled irreversible inhibitor of transglutaminase 2 for quantitative expression profiling in tissues Donat, Cornelius

76-77 S p. S220
artikel
183 Chromophore-conjugated NCS-activated NODAGA is a versatile tool for quantitative prediction of protein-chelator conjugation for 64Cu-immunoPET Seyfried, Dominik

76-77 S p. S10-S11
artikel
184 [11C]HSP990 PET as a translational tool to investigate the aberrant role of Hsp90 in tumors and support the development of Hsp90 therapeutics Cools, Romy

76-77 S p.
artikel
185 11C-labelled oxadiazoles via 11C-labelled acyl amidines through a one-pot, two-step reaction Rydfjord, Jonas

76-77 S p. S74
artikel
186 Click-cleavable 111In/177Lu-labeled DOTA-TCO-trastuzumab for imaging and therapy of breast cancer de Roode, Kim

76-77 S p. S16
artikel
187 Clinical grade [15O]O2 Production for Human Inhalation PET/MRI study Park, Jun Hyung

76-77 S p.
artikel
188 Clinical translation of the GRPR antagonist [99mTc]Tc-maSSS-PEG2-RM26 for targeting prostate tumors Orlova, Anna

76-77 S p. S58
artikel
189 11C-MePro PET/CT Imaging in Normal Volunteers: Initial Evaluation of PET-based Human Biodistribution Yamazaki, Kana

76-77 S p.
artikel
190 [55Co]Co-DOTA-SP4: Towards NK1R-targeted Theranostics of Glioblastoma Laursen, Vigga

76-77 S p.
artikel
191 Combined PD-L1–targeted radionuclide therapy with immunotherapy in two models of colorectal cancer Wen, Xuejun

76-77 S p. S33
artikel
192 Combining Positron Emission Tomography and Hyperpolarized Magnetic Resonance to Interrogate Prostate Cancer Metabolism Enriquez, Jose

76-77 S p.
artikel
193 Come up smelling of roses – Using a real-time radioligand assay to elucidate PD-L1 binding of different ligand classes Donat, Cornelius

76-77 S p.
artikel
194 Comparative analysis of multiple myeloma treatment by CD138 antigen targeting with bismuth-213 and Melphalan chemotherapy Gouard, S.
2014
76-77 S p. e30-e35
nvt p.
artikel
195 Comparative evaluation by SPECT and PET imaging of two immuno-pre-targeting systems in an in vivo model of triple negative breast tumours with anti-EGFR antibodies Briat, Arnaud

76-77 S p. S204-S205
artikel
196 Comparative evaluation of 177Lu-DOTATATE and 90Y-DOTATATE in SSTR II overexpressing Xenograft models for treatment of variable volume neuroendocrine tumours Tawate, Megha

76-77 S p. S213-S214
artikel
197 Comparative in vivo biodistribution and dosimetry in non-human primate of the fibroblast activation protein radiotracers [68Ga]Ga-FAPI-04, [68Ga]Ga-FAPI-46 and [18F]FAPI-74 Tran, Thuy

76-77 S p. S216-S217
artikel
198 Comparative in vivo PET/CT, biodistribution, and excretion study of Cu-64 labeled Polypropylene (PP) nanoplastics via various administration routes in mice Kwon, Mihye

76-77 S p.
artikel
199 Comparing the day-to-day production of [68Ga]Ga-PSMA-11 using Locametz and Illuccix Kits Wang, Ivan

76-77 S p.
artikel
200 Comparison of a radiolabeled somatostatin agonist with an antagonist using the SSTR2 expressing cell line BON-1S in 2D and 3D models Sihver, Wiebke

76-77 S p. S212-S213
artikel
201 Comparison of biodistribution according to administration route for the development of liposome therapeutics Yoo, Ran Ji

76-77 S p. S165
artikel
202 Comparison of [11C] and [18F] labelled D-amino acid tracers for imaging of bacterial infection Lopez-Alvarez, Marina

76-77 S p.
artikel
203 Comparison of cyclotron produced manganese-52 from natural chromium and vanadium targets Nielsen, Karin Michaelsen

76-77 S p. S171-S172
artikel
204 Comparison of DOTA, NODAGA and 15-5 macrocycles as chelators for 64Cu-labelling of immunoconjugates Maisonial-Besset, Aurélie

76-77 S p. S153-S154
artikel
205 Comparison of Evans Blue vs 4-(p-iodophenyl)butyric acid albumin binding moieties for lutetium-177-labeled LLP2A derivatives as theranostic agents for metastatic melanoma Pun, Michael

76-77 S p. S61
artikel
206 Comparison of [18F]FEOBV, [3H]VAT, [3H]MK-6884 and [3H]JNJ-64511070 for imaging Alzheimer’s disease d’Orchymont, Faustine

76-77 S p.
artikel
207 Comparison of [18F]PSMA-1007 with Novel 18F-Labeled PSMA Inhibitor Donat, Cornelius

76-77 S p.
artikel
208 Comparison of [68Ga]Ga precursors for blood cell radiolabeling Bouvry, Christelle

76-77 S p. S57
artikel
209 Comparison of the Biodistribution of [18F]FNP-59 and its Esters Brooks, Allen

76-77 S p.
artikel
210 Comparison of the syntheses of 18F-labelled norepinerphrine transporter tracer [18F]NS12137 using in-house built device and Trasis AllinOne Rajala, Noora

76-77 S p.
artikel
211 Comparison of two cyclen-based phosphonates for development of bone-seeking lutetium-177 radiopharmaceuticals Mitrofanov, Iurii

76-77 S p. S70-S71
artikel
212 Comparison of Voxelized Monte Carlo and OLINDA Dosimetry Methods Towards 67Cu-LLP2A Therapy from 64Cu-LLP2A PET/CT Imaging Data Bellavia, Michael

76-77 S p.
artikel
213 Comparison of 89Zr-Lumi804-IAB2MA and 89Zr-DFO-IAB2MA for PSMA-targeted PET Imaging of Prostate Cancer Ho, Van

76-77 S p.
artikel
214 Complexation of [186Re][Re(CO)3]+ and [99mTc][Tc(CO)3]+ cores with TACN-based chelators Hoerres, Rebecca

76-77 S p.
artikel
215 Computational design, synthesis and radiolabelling of a novel octacoordinate chelator for 89Zr Klingler, Simon

76-77 S p. S45-S46
artikel
216 Conception of Nanoparticles as Diagnostic Agents Mignet, Nathalie

76-77 S p. S2-S3
artikel
217 CONTENTS
76-77 S p. iii
artikel
218 Contents 2014
76-77 S p. IBC-
1 p.
artikel
219 CONTENTS
76-77 S p.
artikel
220 Convenient preparation of 18F-labeled human insulin by Pd-catalyzed S-arylation Humpert, Swen

76-77 S p. S116-S117
artikel
221 Copper-61 as an alternative to Gallium-68 for radiopharmaceutical production: feasibility study and scale-up for clinical doses Fonseca, Alexandra

76-77 S p. S21-S22
artikel
222 Copper catalyzed radiobromination of boronic pinacol esters: utility in PARP inhibitor synthesis Mixdorf, Jason

76-77 S p. S175
artikel
223 Copper-free click labeling with the [99mTc]Tc-tricarbonyl-core using DACN derivatives Mamat, Constantin

76-77 S p. S37
artikel
224 Copper-61 from liquid targets: optimized purification for GMP labelling Fonseca, Alexandra

76-77 S p. S98-S99
artikel
225 Copper-mediated 18F-fluorination of boroxines: a systematic optimization study Bolik, Kim-Viktoria

76-77 S p. S35-S36
artikel
226 Copper mediated radiocyanation of aryl halides Sharninghausen, Liam

76-77 S p. S29-S30
artikel
227 Corrole radiolabelling with 68Ga, 64Cu and 67Cu - a novel approach for theranostic applications in cancer Ekaney, Thomas Kolle

76-77 S p.
artikel
228 Covalent Modification of Black Phosphorus Nanosheets with 89-Zirconium Shen, Jieting

76-77 S p.
artikel
229 11C-Radiolabeling of α-amino acids via aldehyde-promoted isotopic exchange reaction Munch, Maxime

76-77 S p. S29
artikel
230 C(sp3)-H functionalization for access to [11C]amino acids Edgar, Fraser

76-77 S p. S68-S69
artikel
231 64Cu-DOTHA2-PSMA, a novel theranostic agent for prostate cancer and its preclinical animal evaluation Milot, Marie-Christine

76-77 S p. S105
artikel
232 Cu-64 heterodimers targeting GRPR: PSMA expressing cells: in vitro and in vivo investigations Chambers, Claudia

76-77 S p. S8
artikel
233 64Cu-labeled fucoidan nanoparticles for non-invasive PET/CT tumor imaging Kim, Kyungwon

76-77 S p.
artikel
234 64Cu-labeled panitumumab for PET imaging of EGFR+ non-small cell lung cancer: Subcutaneous and metastatic mouse models Wuest, Frank

76-77 S p.
artikel
235 64Cu-labeled TCP-1 probe for PET imaging of colorectal cancer Li, Feng

76-77 S p.
artikel
236 64Cu-Lazarus: bringing our [64Cu]CuCl2 manufacturing system back to life Stimson, Damion

76-77 S p.
artikel
237 Cu-mediated 18F-radiofluorination of various stannylated FDOPA precursors – what is feasible? Kniess, Torsten

76-77 S p.
artikel
238 64Cu production via the 68Zn(p,nα)64Cu nuclear reaction: Targetry, radiochemistry and PET imaging for utility assessment Nelson, Bryce

76-77 S p.
artikel
239 Curcumin-based 68Ga-radiotraces: radiolabeling strategies and bifunctional chelator approach Mari, Matteo

76-77 S p. S69
artikel
240 Current developments in the production of actinium-225 from thorium-229 Benny, Paul

76-77 S p. S42
artikel
241 [11C]Vercirnon - a candidate PET radioligand for the CCR9 chemokine receptor Högnäsbacka, Antonia

76-77 S p.
artikel
242 Cyclic [68Ga] and [18F]AlF-labeled peptides for specific detection of human angiotensin-converting enzyme 2 Wilson, David

76-77 S p. S64-S65
artikel
243 CycloSiFA - Towards the Next Generation of Silicon-Fluoride Acceptor based Positron Emission Tomography (PET) Imaging Probes Jaworski, Carolin

76-77 S p.
artikel
244 Cyclotron-based Production of Lanthanum-133 with High Radionuclidic Purity for Theranostic Purposes Brühlmann, Santiago

76-77 S p.
artikel
245 Cyclotron Production of Copper-67: Exploring the limits Brühlmann, Santiago

76-77 S p.
artikel
246 Cyclotron production of gallium-68 from liquid target: routine production of 68Ga-labelled radiotracers Uhlending, Antje

76-77 S p. S151
artikel
247 Cyclotron-production of manganese-52 for multi-modal imaging applications Boschi, Alessandra

76-77 S p. S46
artikel
248 Cyclotron-production of Mn-52: an update on the METRICS project Martini, Petra

76-77 S p. S169-S170
artikel
249 Cyclotron production of the 64Cu theranostic radiometal using a novel 68Zn sealed solid target Nelson, Bryce

76-77 S p. S171
artikel
250 Cyclotron production of the theranostic pair 133/135La for nuclear medicine Nelson, Bryce

76-77 S p. S2-S3
artikel
251 Cytotoxicity of the bimodal [224Ra]RaCl2 and [212Pb]Pb-TCMC-TP-3 solution in a multicellular tumor spheroid model of osteosarcoma Tornes, Anna Julie

76-77 S p. S15-S16
artikel
252 Delayed 64Cu-DOTA-Rituximab PET image generation for dosimetry using paired image-to-image translation Kim, Kangsan

76-77 S p.
artikel
253 Demonstrating peptide based nanoconstructs as emerging theranostic biomolecules Khan, Irfan

76-77 S p. S87-S88
artikel
254 Demonstration of intracellular pH-weighting PET imaging using a new-type PET probe responsible for monoacylglycerol lipase activity in the brain Yamasaki, Tomoteru

76-77 S p. S112-S113
artikel
255 De novo design of alpha-synuclein small molecule PET tracers Korat, Spela

76-77 S p. S97
artikel
256 De novo design of lead structures for P2Y12 receptor tracer development using in silico methods Stéen, E. Johanna

76-77 S p. S105-S106
artikel
257 Density functional theory experiments offer insight into properties of the Sc-HOPO complex Phipps, Michael

76-77 S p. S71
artikel
258 Design and evaluation of new 99mTc/188Re-labeled TSPO-binding ligands for cancer theragnostic Lee, Kyeongyang

76-77 S p.
artikel
259 Design and synthesis of a new bifunctional chelating agent for 18F-Al/177Lu radiolabelling: theranostic approach Wagner, Laurène

76-77 S p. S12-S13
artikel
260 Design and synthesis of fluorinated pyrazolidine-3,5-dione derivatives as potential P2Y12 receptor PET tracers Stéen, E. Johanna

76-77 S p.
artikel
261 Design and synthesis of monomeric ligands based on published EGFR (epidermal growth factor receptor)-specific peptides for the diagnostic application in malignant transformations Judmann, Benedikt

76-77 S p.
artikel
262 Design and synthesis of novel heptadentate chelates for 89Zr-radiolabelling of antibodies Guillou, Amaury

76-77 S p. S7
artikel
263 Designing and validating the nested neutron spectrometer using for accelerator-based neutron source: Monte Carlo code and artificial intelligence algorithm Tuan, Hoang

76-77 S p. S73
artikel
264 Design space approach to optimise the [68Ga]Ga-Pentixafor radiolabelling process Kaufmann, Jens

76-77 S p. S60
artikel
265 Design, synthesis and biological evaluation of a small-molecule PET imaging agent for imaging PD-L1 expression Xu, Liang

76-77 S p.
artikel
266 Design, synthesis, and biological evaluation of orthosteric ligands for the muscarinic acetylcholine receptors Millard, Marlon

76-77 S p.
artikel
267 Design, Synthesis, and Evaluation of an 18F-Labeling Dendrimer Radiotracer for Positron Emission Tomography (PET) Imaging of Heparanase Pu, Yinglan

76-77 S p.
artikel
268 Detecting EGFR expression in bladder cancer using [89Zr]Zr-DFO-Panitumumab immunoPET imaging Hoang, Tran

76-77 S p. S194
artikel
269 Determination of Association Constants of Macropa-based Chelators for the Stable Complexation of Barium-131 and Lanthanum-133 Blei, Magdalena

76-77 S p.
artikel
270 Determination of 2-chloro-2-deoxy-D-glucose, 2-fluoro-2-deoxy-D-glucose, and glucose in [18F]Fluorodeoxyglucose by capillary electrophoresis Antuganova, Yulia

76-77 S p. S80
artikel
271 Developing a Novel Microfluidics-based 86Y Purification Strategy for Rapid and Efficient Radiopharmaceutical Production Ta, Robert

76-77 S p.
artikel
272 Development and application of a fully automated multi-function cassette module Mortenon M1 for radiopharmaceutical synthesis Cui, Fang-Bo

76-77 S p.
artikel
273 Development and biological evaluation of 18F-labeled adenosine-A1-receptor partial agonists Evcüman, Sibel

76-77 S p. S9
artikel
274 Development and evaluation of fully automated F-18 cromolyn diethyl ester labeling via multi step reaction as potential therapeutics for Alzheimer’s Disease for brain PET imaging Moon, Sung-Hyun

76-77 S p.
artikel
275 Development and evaluation of new small molecule PET-radiotracers for the molecular imaging of inflammatory processes targeting S100A9 Steiner, Simon

76-77 S p. S44-S45
artikel
276 Development and evaluation of novel TSPO PET tracers with low binding sensitivity to human single nucleotide polymorphism rs6971 Beaino, Wissam

76-77 S p.
artikel
277 Development and evaluaton of a trans-cyclooctene (TCO) probe for pretargeted PET imaging Adhikari, Karuna

76-77 S p. S176
artikel
278 Development and exploration of bifunctional chelating ligands for mercury-197m/g Randhawa, Parmissa

76-77 S p. S13-S14
artikel
279 Development and First-in-Man Study of a Novel Tetrapeptidic CCK-2R-Targeted Compound with Improved Metabolic Stability and Pharmacokinetics Günther, Thomas

76-77 S p.
artikel
280 Development and initial evaluation of two [99mTc]Tc complexes derived from a fibroblast activating protein (FAP) inhibitor Decuadra, Paula

76-77 S p. S39-S40
artikel
281 Development and in vitro evaluation of a copper-64 radiolabeled antibody for targeting the CXCR4 receptor in human multiple myeloma Métivier, Cassandra

76-77 S p. S203-S204
artikel
282 Development and in vivo Evaluation of a Novel 18F-labeled Aromatase Inhibitor PET Radiotracer in Rodent Models for Cancer Li, Songye

76-77 S p.
artikel
283 Development and preclinical evaluation of [11C]HSP990 as an Hsp90 PET brain probe and potential biomarker for diagnosis and follow up of CNS disease progression Cools, Romy

76-77 S p. S93-S94
artikel
284 Development and pre-clinical evaluation of new 64Cu-NOTA-folate conjugates for PET imaging of folate receptor-positive tumors Alhokbany, Norah

76-77 S p. S74
artikel
285 Development and preclinical evaluation of PSMA-targeting trimers based on the NOTI chelating platform Martin, Sebastian

76-77 S p. S41
artikel
286 Development and preliminary evaluation of the fluorine-18 labeled benzamido-dihydroindene derivative [18F]FBAIN as a potential radiotracer for PET imaging of the chemokine receptor CXCR5 Lindemann, Marcel

76-77 S p. S200-S201
artikel
287 Development and radiolabelling of fluorinated ligands targetting the Aryl hydrocarbon Receptor Vercouillie, Johnny

76-77 S p.
artikel
288 Development and Radiosynthesis of [11C]MODAG-005 for in vivo Imaging of alpha-synuclein Pathology Maurer, Andreas

76-77 S p.
artikel
289 Development and validation of [18F]FDG dual radiosynthesis on a MX cassette with a NEPTIS® module Joyard, Yoann

76-77 S p. S128
artikel
290 Development of a Candidate PET Radioligand for Receptor Interacting Protein 1 Kinase (RIPK1) and Evaluation in Healthy Monkey Jana, Susovan

76-77 S p.
artikel
291 Development of a 64Cu-labeled immuno-PET probe for imaging Sialyl Lewis X in breast cancer Kaur, Jatinder

76-77 S p. S221
artikel
292 Development of a dual imaging probe for bimodal PET/ two-photon NIRF imaging Jouad, Kamal

76-77 S p. S167-S168
artikel
293 Development of a [18F]PD-L1 radiotracer to profile cancer patient response to immunotherapy Zecca, Henry

76-77 S p. S189
artikel
294 Development of a highly hydrophilic 18F-tetrazine for pre-targeting approaches in PET imaging Perrio, Cecile

76-77 S p. S84
artikel
295 Development of a highly specific 18F-labeled benzimidazolone-based sigma-2 receptor radioligand for brain tumor imaging Huang, Henry

76-77 S p.
artikel
296 Development of aliphatic 18F-labeled tetrazines suitable for pretargeted PET imaging Battisti, Umberto

76-77 S p. S178-S179
artikel
297 Development of alpha particle emitting radionuclide therapy according to GMP guidelines for treatment of mCRPC Hooijman, Eline

76-77 S p. S22-S23
artikel
298 Development of a 99mTc-NTP 15-5 kit for an early clinical trial Sophie, Levesque

76-77 S p. S145
artikel
299 Development of a [99mTc]Tc-PVP nanogel for controlled release of 5-FU Ges-Naranjo, Adrian

76-77 S p. S84-S85
artikel
300 Development of an effective electro-amalgamation technique to debulk Eu(III) from Eu(III)/Tb(III) mixtures: Towards future application in the separation of 155Tb from alpha-irradiated 153Eu Serasinghe, Madhushan

76-77 S p.
artikel
301 Development of a new class of Mn(II) complexes for MRI applications Boschi, Alessandra

76-77 S p. S69-S70
artikel
302 Development of a New 64Cu-Semicarbazone Complex: Potential Theragnostic Radiopharmaceutical for Hypoxic Tumor Alhokbany, Norah

76-77 S p.
artikel
303 Development of a new reagent for 18F-trifluoroethylation of secondary amine Choi, Ji Young

76-77 S p.
artikel
304 Development of an 18F-labeled MutT Homolog 1 (MTH1) radiotracer ([18F]WC-7-73): synthesis, radiosynthesis and evaluation Chu, Wenhua

76-77 S p.
artikel
305 Development of an in-house 188W/188Re generator for rhenium-188 production and radiolabelling studies Melis, Diana

76-77 S p. S38
artikel
306 Development of a novel Azabenzimidazoles-Based PET radioligands for γ-8 dependent transmembrane AMPA receptor regulatory protein imaging Chen, Jiahui

76-77 S p.
artikel
307 Development of a novel carbon-11 radiotracer for brain PET imaging of sulfonylurea receptors 1 Caillé, Fabien

76-77 S p. S33-S34
artikel
308 Development of a novel 68Ga-labeled benzo[h]quinoline-based FAP-targeted PET tracer: Synthesis, preclinical evaluation, and comparison with [68Ga]Ga-FAPI-04 Lin, Kuo-Shyan

76-77 S p.
artikel
309 Development of a novel PET ligand for imaging AMPA receptor Chen, Jiahui

76-77 S p.
artikel
310 Development of a novel PET tracer for imaging of γ-8 dependent transmembrane AMPA receptor regulatory protein Yu, Qingzhen

76-77 S p. S66-S68
artikel
311 Development of a novel reversible monoacylglycerol lipase PET tracer bearing a morpholine-3-one scaffold He, Yingfang

76-77 S p. S5-S6
artikel
312 Development of Approaches for High-Throughput Experimentation in Radiochemistry Webb, Eric

76-77 S p.
artikel
313 Development of a PSMA Heterogeneous Tumor Model for Targeted Radiotherapy Payne, Rachel

76-77 S p.
artikel
314 Development of a radiolabeled self-assembled nanoparticle as an imaging probe for CD44-expressing tumors Tanaka, Toshie

76-77 S p. S83-S84
artikel
315 Development of a radiotheranostics agent with albumin binder aiming to increase the therapeutic effects for At-211 labeled RGD peptide Echigo, Hiroaki

76-77 S p.
artikel
316 Development of a (+)RESCA-triaryl phosphine for in vitro radiolabeling using the Staudinger ligation Biti, Anisa

76-77 S p.
artikel
317 Development of a small-molecule CXCR3 PET radiotracer for atherosclerosis imaging in live animals Alluri, Santosh Reddy

76-77 S p. S17
artikel
318 Development of a stabilized GRPR antagonist for targeted cancer theranostics Abouzayed, Ayman

76-77 S p. S24
artikel
319 Development of a stable peptide-based PET tracer for detecting CD133-expressing cancer cells Hu, Kuan

76-77 S p. S195
artikel
320 Development of Astatine-211 labeling reaction using aryliodonium ylide Ogawa, Mikako

76-77 S p.
artikel
321 Development of automatic synthesis method for [18F]Fluoromethyl-PBR28 using two synthesizer Cho, Yong-Hyun

76-77 S p. S123
artikel
322 Development of bispecific theranostic ligand targeting the prostate specific membrane antigen (PSMA) and gastrin releasing peptide (GRPR) receptor Bouzioti, Danai

76-77 S p. S29-S30
artikel
323 Development of BODIPY-Tetrazines as Pretargeted Bimodal Fluorescent-Radioactive Tracers Herth, Matthias

76-77 S p.
artikel
324 Development of CD44-targeted 64Cu-labeled peptide for diagnosis of cancer stem cells Eom, Sairan

76-77 S p.
artikel
325 Development of C-terminal modified long-acting DOTA-JR11 analogs for optimized treatment of NETs Handula, Maryana

76-77 S p.
artikel
326 Development of 11C-Tucatinib as a potential HER2-targeting PET radiotracer Müller, Marius

76-77 S p. S206
artikel
327 Development of [64Cu]Cu-NGUL and [67Cu]Cu-NGUL as a matched-pair theranostic for prostate cancer Seo, Hye Yeon

76-77 S p. S61
artikel
328 Development of discoidal phospholipid bilayer nanoparticles with styrene maleic acid copolymer for diagnosis and therapy of intractable cancers Munekane, Masayuki

76-77 S p. S83
artikel
329 Development of FAP targeted radiopharmaceuticals Xu, Mengxin

76-77 S p. S221
artikel
330 Development of [18F]Fluoromannitol, a Novel Radiopharmaceutical for Infection Imaging Simpson, Spenser

76-77 S p.
artikel
331 Development of [18F]fluoro-4-(vinylsulfonyl)benzene for chemoselective cysteine radiofunctionalization of peptides McDaniel, James

76-77 S p. S75-S76
artikel
332 Development of finely tuned liposome nanoplatform for effective macrophage targeting and depletion Choi, Tae Hyeon

76-77 S p.
artikel
333 Development of five Polar and Highly Reactive Tetrazines for Pretargeted Imaging Müller, Marius

76-77 S p.
artikel
334 Development of 18F-labeled agonist for imaging STING in the tumor microenvironment Liu, Huanhuan

76-77 S p. S19-S20
artikel
335 Development of 18F-Labeled tetrazines for pretargeted imaging across the blood-brain barrier Shalgunov, Vladimir

76-77 S p. S103-S104
artikel
336 Development of 18F-labeled tracer for noninvasive PET imaging of the STING expression in tumor microenvironment Fang, Jianyang

76-77 S p. S187-S188
artikel
337 Development of 18F-Labelled CXCR4-Targeted Peptide Radiopharmaceuticals Through Strain-Promoted Click Chemistry Mason, Julia

76-77 S p.
artikel
338 Development of freeze-dried kit for one-step expeditious preparation of [99mTc]Tc-PSMA-T4 Wojdowska, Wioletta

76-77 S p. S146
artikel
339 Development of freeze-dried kits for one-step expeditious formulation of [68Ga]Ga-NODAGA-JR11 Satpati, Drishty

76-77 S p. S47
artikel
340 Development of [68Ga]Ga-DOTA-4AH29, a radiolabeled single-domain antibody for PET imaging of FAP-α expression in cancer Berdal, Marion

76-77 S p.
artikel
341 Development of 68Ga-labeled riboflavin analognes for RFVTs-targeted PET imaging Chen, Yingxi

76-77 S p.
artikel
342 Development of gallium coordinate nonapeptides as candidates for PET imaging of neuropeptide Y1 receptors in oncology Hetsron, Amit

76-77 S p. S116
artikel
343 Development of 125I-labeled tetrazines Bidesi, Natasha

76-77 S p. S52-S53
artikel
344 Development of 123I-labelled acrylamides as radiotracer candidates for transglutaminase 2 Laube, Markus

76-77 S p. S79-S80
artikel
345 Development of liposome-based drug-releasing radiopharmaceutical for theranosis Kim, Jiyoon

76-77 S p.
artikel
346 Development of locally injectable thermo-sensitive polymer micelle using as carriers for combined radio- and chemotherapy of cancers Makino, Akira

76-77 S p.
artikel
347 Development of 99mTc-labeled hexavalent c(RGDfK) peptide with optimized linker structure for in vivo imaging of integrin αvβ3 Mizuno, Yuki

76-77 S p. S7-S8
artikel
348 Development of new aptamer-labeled radiopharmaceuticals Ozerskaya, Anastasia

76-77 S p. S43
artikel
349 Development of novel 64Cu-labelled antibodies for PET-CT imaging of TREM2 Shojaei, Monireh

76-77 S p. S104
artikel
350 Development of novel PSMA target therapeutic radiopharmaceuticals by modification with albumin binder Lee, Kyongkyu

76-77 S p. S198-S199
artikel
351 Development of novel sulfur-rich ligands for incorporation into mercury-197m/g radiopharmaceuticals Randhawa, Parmissa

76-77 S p. S8
artikel
352 Development of novel tripodal chelates for the stable chelation of theranostic radiolanthanides and actinides Carbo-Bague, Imma

76-77 S p. S148
artikel
353 Development of 203Pb-labeled SSTR2 radioligands for neuroendocrine tumors (NETs) imaging Chapeau, Dylan

76-77 S p. S54-S55
artikel
354 Development of peptide probes for imaging of CD206 positive macrophages in cancer Zhang, Bo

76-77 S p. S40
artikel
355 Development of PSMA-targeted vectors containing an albumin binder and a cleavable linker Murce, Erika

76-77 S p. S48-S49
artikel
356 Development of (radio)fluorinated aminobenzothiazole derivatives as potential adenosine A2A receptor ligands Renk, Dana

76-77 S p. S100-S101
artikel
357 Development of radio-halogen-labeled PSMA-targeting ligand with high in vivo stability Yamashita, Tomoki

76-77 S p.
artikel
358 Development of radiolabeled polymer nano- and micron-sized carriers Muslimov, Albert

76-77 S p. S86-S87
artikel
359 Development of reversible monoacylglycerol lipase PET tracers with improved brain uptake He, Yingfang

76-77 S p. S36
artikel
360 Development of silicon fluoride acceptor (SiFA)-conjugated antibodies targeting TREM2 and Poly-GA repeats as new tracers for PET imaging of neurodegenerative diseases Shojaei, Monireh

76-77 S p. S37
artikel
361 Development of site-specifically labelled single-domain antibody PET probe for monitoring PD-L1 expression in cancer Chen, Yinfei

76-77 S p. S200
artikel
362 Development of small molecule PET-tracers targeting PD-L1 Bamminger, Karsten

76-77 S p.
artikel
363 Development of Solid Target Technologies for 225Ac Production with Proton Bombardment Malinconico, Mario

76-77 S p.
artikel
364 Development of targeted 161Tb-radiolabeled nanoparticles Lemaître, Tom

76-77 S p. S69
artikel
365 Development of Terbium-161 Based VLA-4 Targeted Theranostics Iweha, Ejike

76-77 S p.
artikel
366 Development of two [99mTc]Tc(CO)3 complexes targeting the androgen receptor Decuadra, Paula

76-77 S p. S38-S39
artikel
367 Development of versatile dual-modality imaging probes based on a GRPR antagonist for preoperative imaging and image-guided surgery of prostate cancer Handula, Maryana

76-77 S p. S82
artikel
368 Development of 89Zr-antibody-PET imaging to evaluate improved brain targeting via transferrin receptor 1: the chelator matters Wuensche, Thomas

76-77 S p. S24
artikel
369 Development of 89Zr-radiolabeled paclitaxel-loaded polymeric micelles for potential applications in personalized treatment of triple-negative breast cancer Sadeghzadeh, Masoud

76-77 S p. S163-S164
artikel
370 Diagnostic efficacy of 68Ga-DOTAGA-Duramycin for early detection of anthracycline induced cardiotoxicity in Wistar rats Gill, Gurvinder

76-77 S p. S65-S66
artikel
371 Differential and staging diagnosis for NSCLC patients With [68Ga] Ga-DOTA-FAPI-04 and 2-[18F]FDG PET/CT Zhou, Xin

76-77 S p. S46-S47
artikel
372 Diphosphine bifunctional chelators: [99mTc][TcO2(DP-PSMAt)2]+ tracers for PSMA imaging of prostate cancer Hungnes, Ingebjorg

76-77 S p. S5-S6
artikel
373 Direct carbon-11 isotopic radiolabeling of Domperidone from [11C]CO2: application to in vivo brain PET imaging under P-glycoprotein inhibition Caillé, Fabien

76-77 S p. S91
artikel
374 Direct clinical comparison of scaffold proteins [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3 for imaging of HER2-positive breast cancer Tolmachev, Vladimir

76-77 S p.
artikel
375 Direct 11C-methylation of amines using cyclotron-produced [11C] CO2 Kealey, Steven

76-77 S p. S30
artikel
376 Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: antagonist versus agonist Cleeren, Frederik

76-77 S p.
artikel
377 Direct 18F fluorination of covalent organic framework (COF) nanosheets for PET molecular imaging Kim, Dong Wook

76-77 S p. S161-S162
artikel
378 Direct 18F-labeling of a dimeric RGD peptide via F-nucleophilic substitution on a phosphonate prothesis Wang, Chao

76-77 S p. S76
artikel
379 Discovery of [18F]F-687-TCO: An Optimized Tracer for Pretargeted PET Imaging in the CNS Cook, Brendon

76-77 S p.
artikel
380 Discovery, preclinical validation and early human imaging with [11C]AZ14193391 – the first blood-brain barrier permeable and subtype selective PARP1 PET radioligand Cortes Gonzalez, Miguel Angel

76-77 S p.
artikel
381 DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapy Piron, Bérengère
2014
76-77 S p. e75-e83
nvt p.
artikel
382 DOTA derivatives with sulfur containing side chains as an attempt to thwart the biological instability of copper labelled radiotracers Tosato, Marianna

76-77 S p. S6-S7
artikel
383 DOX-PEG-198AuNPs-PEG-Tmab: multimodal radiobioconjugate for targeted radionuclide therapy of HER2-positive cancers Zelechowska-Matysiak, Kinga

76-77 S p. S165-S166
artikel
384 Dual labelling platform for theranostics: PSMA-targeted imaging with 99mTc and therapy with 188Re Hungnes, Ingebjorg

76-77 S p.
artikel
385 Dual PET imaging of microtubule destabilization and synaptic integrity in a mouse model of AD Damuka, Naresh

76-77 S p.
artikel
386 Dual targeting of PD-L1 and integrin avb3 with a peptide tracer Hu, Kuan

76-77 S p.
artikel
387 Economical radiosynthesis optimization using a multi-reaction microdroplet chip platform Rios, Alejandra

76-77 S p. S65-S66
artikel
388 Editorial Board
76-77 S p. i
artikel
389 Editorial Board
76-77 S p. ii
artikel
390 Editorial Board 2014
76-77 S p. IFC-
1 p.
artikel
391 Editorial Board
76-77 S p. i
artikel
392 Editorial Board
76-77 S p.
artikel
393 Effect of dissolution and exposure of [18F]F– on nucleophilic 18F-fluorination Mou, Zhaobiao

76-77 S p. S77-S78
artikel
394 Effect of (2-hydroxypropyl)-β-cyclodextrin on the solubility and in vivo behavior of the myocardial perfusion imaging agent [18F] FRho6G-DEG Inkster, James

76-77 S p. S58
artikel
395 Effect of metal impurities on the radiolabeling efficiency of DOTA with terbium-161 and lutetium-177: a comparative study Opsomer, Tomas

76-77 S p. S57-S58
artikel
396 Effects of linker and binding motif modifications on tumor uptake and distribution of 99mTc-labeled HYNIC-based PSMA-targeting SPECT tracers Lu, Kelly

76-77 S p.
artikel
397 Effects of Polyethylene Glycol and 8-Aminooctanoic Acid Linkers on Melanoma Uptake of [99mTc]-Tricarbonyl-NOTA-Conjugated Lactam-Cyclized Alpha-MSH Peptides Qiao, Zheng

76-77 S p.
artikel
398 Effects of solvents on the yield of 6-bromo-7-[11C]methylpurine Okamura, Toshimitsu

76-77 S p.
artikel
399 Effects of uncharged linker-modification of PSMA-617-based inhibitors on targeting properties and the pharmacokinetic profile Geis, Nicolas

76-77 S p.
artikel
400 Efficacy and imaging evaluation of 177Lu-labeled antibody-drug conjugates as a potential theranostic agent for HER2-positive breast cancer Kim, Heejung

76-77 S p. S104-S105
artikel
401 Efficient and cGMP-Compliant Manufacturing of C-11 PIB using Sep-Pak: A single cassette module approach for multiple productions Nair, Manoj

76-77 S p.
artikel
402 Efficient and mild copper-labelling of sensitive targeting vectors with novel triazamacrocyclic chelator Hierlmeier, Ina

76-77 S p.
artikel
403 Efficient cartridge-based synthesis of a novel [18F]tetrazine for large molecule labelling Rokka, Johanna

76-77 S p. S115
artikel
404 Efficient chelation of 134Ce/La using the macrocyclic chelators DOTA and Macropa as potential PET imaging agents Bobba, Kondapa

76-77 S p. S8-S9
artikel
405 Efficient 18F-fluorination for dimorpholinophosphinic fluoride Wang, Tao

76-77 S p. S79
artikel
406 Efficient radiosynthesis of a new folate receptor-targeting PET tracer, [18F]fluoronicotinic acid labeled folate, for imaging lung fibrosis Zhuang, Xiaoqing

76-77 S p.
artikel
407 EGSnrc Monte Carlo calculated dose distribution around brachytherapy sources Tuan, Hoang

76-77 S p. S175-S176
artikel
408 Electronic cigarette aerosol deposition of [11C]nicotine in human subjects: radiosynthesis and vaping apparatus development VanBrocklin, Henry

76-77 S p. S137-S138
artikel
409 Electrophilic Synthesis of 6-L-[18F]FDOPA with [18F]F2: a progress report on gas target of Cyclotron TR-Flex Kniess, Torsten

76-77 S p.
artikel
410 Enabling insights into the cytochrome P450 isoform specific metabolism of radiotracers by CYP overexpressing hepatoblastoma cell lines Lemm, Sandy

76-77 S p. S66-S67
artikel
411 Enantioselective Synthesis and Biological Evaluation of (R)- and (S)-[18F]OF-NB1 to Visualize GluN2B Subunit-Containing NMDA Receptors Rong, Jian

76-77 S p.
artikel
412 ENBPI ligand for 68Ga: synthesis, radiolabeling optimization, and pilot myocardial perfusion imaging with ECG-gated PET Muzzioli, Riccardo

76-77 S p. S57
artikel
413 Enhanced blood retention and tumor uptake of PSMA-targeting, 225Ac-labeled radioconjugates Reissig, Falco

76-77 S p. S30-S31
artikel
414 Epigenetic modifiers in somatostatin type 2 receptor radionuclide theranostics and early transcriptional response of mouse pheochromocytoma models Ullrich, Martin

76-77 S p. S11
artikel
415 Establishing the host-guest pretargeting platform with adamantane guest ligands in a xenograft model Jallinoja, Vilma

76-77 S p. S18-S19
artikel
416 Establishing the role of “Design of Experiments” (DoE) in the tracer development pipeline: the synthesis and evaluation of [18F] talazoparib as a case study Bowden, Gregory

76-77 S p. S78-S79
artikel
417 Evaluating the effect of an albumin binder for targeting melanoma tumors with 89Zr-Lumi804-Lys-pIBA-PEG4-LLP2A Fong, Cyril

76-77 S p.
artikel
418 Evaluating the Interplay of 89Zr-labeled Radioimmunoconjugates and Fc Receptors in Genetically Engineered Mouse Models Rodriguez, Cindy

76-77 S p.
artikel
419 Evaluating the in vivo distribution and stability of a 161Tb-labeled nanobody for potential cancer therapy Cassells, Irwin

76-77 S p. S50
artikel
420 Evaluating the potential of CCR2 for the early detection of head and neck cancer Kang, Yeona

76-77 S p.
artikel
421 Evaluating the radionuclide theranostic potential of a MUC13-targeting antibody in colorectal cancer Coll, Ryan

76-77 S p.
artikel
422 Evaluation of Actinium-225 radiolabeled cyclized alpha-melanocyte stimulating hormone (CycMSH) peptide for targeted alpha therapy Brown, Victoria

76-77 S p. S101
artikel
423 Evaluation of Affibody molecule Z09591 for PET imaging in fibrosis Wegrzyniak, Olivia

76-77 S p. S44
artikel
424 Evaluation of a multifunctional blood-brain barrier co-culture model prepared from rat primary brain endothelial cells and astrocytes: first results Schneider, Daniela

76-77 S p. S102-S103
artikel
425 Evaluation of an open-source 3D printed microfluidic system for the production of radiopharmaceuticals Cotton, Jonathan

76-77 S p. S123-S124
artikel
426 Evaluation of a Radiofluorinated Probe for Imaging Cytochrome P450 46A1 Zhao, Chunyu

76-77 S p.
artikel
427 Evaluation of biodistribution of a novel sugar-conjugated platinum complex labeled with 191Pt in mice Omokawa, Marina

76-77 S p.
artikel
428 Evaluation of 134Ce/La pair as a PET imaging surrogate for 225Ac radiotherapeutics Bobba, Kondapa

76-77 S p.
artikel
429 Evaluation of [11C]HSP990 as a PET probe for in vivo visualisation of heat shock protein 90 in tumours Narykina, Valeria

76-77 S p. S207-S208
artikel
430 Evaluation of 64Cu-labeled DOTA-polymer functionalized peptides Villas Boas, Cristian Wieczorek

76-77 S p. S63-S64
artikel
431 Evaluation of [18F]FPy-T140 derivative PET imaging agents for CXCR4 in human cancer xenograft mouse models Phelps, Tim

76-77 S p. S20
artikel
432 Evaluation of 18F-Labelled Radiotracers for Imaging of Sigma-2 Receptor in the Brain of Nonhuman Primates Wenn, Mike

76-77 S p.
artikel
433 Evaluation of [18F]RM273 for sigma2-receptor imaging in an experimental orthotopic glioblastoma model Guendel, Daniel

76-77 S p. S184
artikel
434 Evaluation of in vivo behavior of Na[F-18]F as a single substance and Na[F-18]F-contained mouthwashes via intra-trachea instillation Kim, Dong Hyun

76-77 S p.
artikel
435 Evaluation of Iododiflunisal on amyloid-β deposition in 5xFAD Alzheimer’s disease mouse model by Positron Emission Tomography imaging. Zapero, Claudia Esposito

76-77 S p.
artikel
436 Evaluation of kit-based synthesis and delivery of 99mTc zoledronic acid as bone cancer imaging radiopharmaceutical Ng, Yen

76-77 S p. S208
artikel
437 Evaluation of 3,4,3-LI(1,2-HOPO) as a chelator for radioscandium based radiopharmaceuticals Phipps, Michael

76-77 S p. S155-S156
artikel
438 Evaluation of lysine modifications in the PSMA-targeting pharmacophore using positron emission tomography imaging in a preclinical model of human prostate cancer Zhang, Chengcheng

76-77 S p.
artikel
439 Evaluation of neuroinflammatory radiotracers in chronic traumatic encephalopathy Varlow, Cassis

76-77 S p. S109
artikel
440 Evaluation of 3p-C-DEPA as potential 225Ac-chelator Ahenkorah, Stephen

76-77 S p. S49
artikel
441 Evaluation of PET-based Human Biodistribution of a Novel Amino Acid 11C-MeLeu PET/CT Imaging in Normal Volunteers Nishii, Ryuichi

76-77 S p.
artikel
442 Evaluation of polyazamacrocycles functionalized with sulphur-containing pendant arms as potential chelators for theranostic silver-111 Tosato, Marianna

76-77 S p. S158
artikel
443 Evaluation of Pyridyl Benzofuran Derivative for Targeted Alpha Therapy of Alzheimer’s Disease Bender, Aidan

76-77 S p.
artikel
444 Evaluation of (R)- and (S)-18F-PF-NB1 in non-human primates for imaging the GluN2B subunits of NMDA receptor complex Wenn, Mike

76-77 S p.
artikel
445 Evaluation of [47Sc]Sc-HOPO toward radioscandium based radiopharmaceuticals Phipps, Michael

76-77 S p. S91-S92
artikel
446 Evaluation of selective Sc(III) complexes with a non-macrocyclic ligand for theranostics applications Huclier, Sandrine

76-77 S p. S56
artikel
447 Evaluation of tetramethylammonium salts in minimalist-like SNAr radiofluorinations Humpert, Swen

76-77 S p.
artikel
448 Evaluation of the binding characteristics of [18F]FBVM in non-human primates, a new radiotracer for imaging the vesicular acetylcholine transporter in vivo using positron emission tomography Serriere, Sophie

76-77 S p. S94-S95
artikel
449 Evaluation of the combinationally glycated albumin nanoplatform for targeting the tumor microenvironment with minimized reticuloendothelial system uptake using PET imaging Kim, JinSil

76-77 S p.
artikel
450 Evaluation of the effect of macrocyclic ring size on Pb(II) and Cu(II) complex stability in pyridyl containing chelators McNeil, Brooke

76-77 S p. S154
artikel
451 Evaluation of the effects of conjugation chemistry and different LET radionuclides in prostate cancer xenograft Strand, Joanna

76-77 S p.
artikel
452 Evaluation of the therapeutic effect of taurine against Alzheimer’s disease using mGluR5 PET Lee, Kyo Chul

76-77 S p. S93
artikel
453 Evaluation of the tumour targeting profile and characterisation of the metabolites for a novel stabilised minigastrin analogue Hörmann, Anton

76-77 S p. S194-S195
artikel
454 Evaluation of tin dioxide as an inorganic-based stationary phase for a potential 44Ti/44Sc generator Deri, Melissa

76-77 S p. S43
artikel
455 Evaluation of 44Ti/44Sc generator and 44Sc-post-processing procedures for radiopharmaceutical purposes: [44Sc]Sc-PSMA-617 and [44Sc]Sc-PSMA-I&T synthesis Larenkov, Anton

76-77 S p. S152
artikel
456 Examination of bifunctional chelates for efficient labeling of affibodies with 52Mn Brezovcsik, Karoly

76-77 S p. S147-S148
artikel
457 Examining the synergistic effect of radioimmunotherapy and immune checkpoint blockade for the treatment of metastatic melanoma Allen, Kevin

76-77 S p. S33
artikel
458 Expanding the radiochemist’s toolbox: carbon-11 labelled formamides and isocyanides for PET tracer synthesis Bonnemaire, Coralie

76-77 S p. S10
artikel
459 Experience on clinical scale formulation of ready to use [90Y] Y-hydroxyapatite microparticles utilizing 90Y produced in research reactor Chakraborty, Sudipta

76-77 S p. S140
artikel
460 Exploration of 99Tc pincer-type complexes interacting with small molecules Besmer, Manuel

76-77 S p. S6
artikel
461 Exploration of the fundamental chemistries of Ru and Pd for establishing 103Ru/103mRh Auger generator and 103Pd/103mRh in vivo generator Thery, Marie

76-77 S p. S150-S151
artikel
462 Exploration the fluorine chemistry to develop the [18F]FS1P1 as a promise F-18 radiotracer for imaging S1PR1 in vivo Qiu, Lin

76-77 S p. S11-S12
artikel
463 Exploring a Tristhione Scorpionate Ligand as a Suitable Chelator for the Theranostic Pair Antimony-119 and Antimony-117 Gé, Lorraine

76-77 S p.
artikel
464 Exploring bpcd ligand for theranostic radiopharmaceutical application Cazzola, Emiliano

76-77 S p. S54
artikel
465 Exploring new strategies for technetium radiolabeled [1,2,4,5] tetrazines Rodriguez, Gonzalo

76-77 S p. S60-S61
artikel
466 Exploring the chemical scope of light-activated protein conjugation and the photoradiosynthesis of 89Zr-antibodies Earley, Daniel

76-77 S p. S94
artikel
467 Exploring the potential of high-specific activity samarium-153 for targeted radionuclide therapy with [153Sm]Sm-DOTA-TATE Vermeulen, Koen

76-77 S p. S57
artikel
468 Extracorporeal clearing traps based on tetrazine ligation for pretargeted therapy and diagnostics Shalgunov, Vladimir

76-77 S p. S212
artikel
469 Extraction chromatographic separation of selenium and arsenic for accelerator target processing Baumeister, Jakob

76-77 S p. S92-S93
artikel
470 Extraction of 68Ga medical radioisotopes from Zn nitrate liquid target using atomic layer deposited microfluidics Santoso, Albert

76-77 S p.
artikel
471 [18F]AlF and RESCA: a novel method for radiolabeling of Affibody molecules Lechi, Francesco

76-77 S p.
artikel
472 [18F]ALX5406: a brain-penetrating prodrug for GlyT1-specific PET imaging Hoffmann, Chris

76-77 S p. S45
artikel
473 Fast, efficient, one-step purification of cyclotron produced lanthanum-135 using HDEHP-based resin and dilute hydrochloric acid Nielsen, Karin Michaelsen

76-77 S p. S18-S19
artikel
474 18F-Chemistry in HPLC vials - a microliter scale radiofluorination approach Laube, Markus

76-77 S p. S61
artikel
475 [18F]Difluorocarbene for positron emission tomography Sap, Jeroen

76-77 S p.
artikel
476 [18F]FEPPA PET imaging for monitoring the neuroinflammation status in a Lactacystin-induced Parkinson disease animal model. Chiu, Ching-Hung

76-77 S p.
artikel
477 [18F]FLUDA – A promising PET probe for the non-invasive assessment of the A2A adenosine receptor Lai, Thu Hang

76-77 S p.
artikel
478 18F-Fluorination Reactions and Optimizations using a Parallel Synthesis Reactor Donat, Cornelius

76-77 S p.
artikel
479 [18F]Fluoroform radiolabelling of the CHK1 inhibitor CCT245737 Sharma, Gitanjali

76-77 S p. S48-S49
artikel
480 3-[18F]Fluoro-5-hydroxy- and 3-[18F]fluorophenylserines: Preparation and initial biological evaluation Kolks, Niklas

76-77 S p.
artikel
481 5-[18F]Fluoro-m-tyrosine (5-[18F]FMT) - a novel promising tracer for dopaminergic imaging Vus, Stefanie

76-77 S p. S38
artikel
482 [18F]FS-DPA: a novel PET probe for imaging of neuroinflammation easily accessible via SuFEx click labeling Walter, Nils

76-77 S p. S110
artikel
483 18F-Functionalization of sulfur heteroatom frameworks via isotopic exchange in hydrous organic media Kim, Min Pyeong

76-77 S p. S37
artikel
484 [18F]GP1, a novel PET tracer investigated for the detection of thrombi in LVADs and for the diagnosis of valve thrombosis Hugenberg, Verena

76-77 S p.
artikel
485 [18F]hGTS13 for imaging of xC − transporter activity in high-grade glioma Kendrili, M. Tansel

76-77 S p.
artikel
486 First experiences with the SST2R-antagonist [68Ga]Ga-DATA5m-LM4 for PET imaging of tumors: preclinical comparison with [68Ga] Ga-DOTA-LM3 Kanellopoulos, Panagiotis

76-77 S p. S16-S17
artikel
487 First-In-Class Diagnostics Targeting Neuropeptide Y1 Receptor (Y1R): Enabling Molecular Imaging of Metastatic Breast Cancer Rahimi, Marwa Nadia

76-77 S p.
artikel
488 First-in-human evaluation of [99mTc]Tc-(HE)3-G3, a novel DARPin-based agent for imaging of HER2 expression in breast cancer Tolmachev, Vladimir

76-77 S p. S17-S18
artikel
489 First in-human studies of the glutamate transporter EAAT2 radiotracer methyl N4-(7-[18F]fluoro-9H-fluoren-2-yl)asparginate (RP-115): radiosynthesis and biodistribution evaluation Nillo, Ryan Michael

76-77 S p.
artikel
490 First microvolume metal-mediated synthesis of [18F]FDOPA in a microreactor Lu, Yingqing

76-77 S p. S15-S16
artikel
491 First time evaluation of 45Ti for radiolabeling of NOTA and DOTA chelators Milton, Stefan

76-77 S p.
artikel
492 F-18 labeled azaindole derivatives as PET imaging tracer for tau protein Kim, Dong Wook

76-77 S p.
artikel
493 18F-labeled imidazole naphthyridine derivatives as Tau imaging agents in Alzheimer’s Disease Liu, Tianqing

76-77 S p.
artikel
494 18F-labeled indole-based analogs with chiral 2,3-dihydroxyfluorobutoxy side chain as highly selective sigma-2 receptor probes for tumor imaging An, Xiaodan

76-77 S p. S196-S197
artikel
495 18F labelled albumin binding synthons enabling PET imaging and enhanced target accumulation of biomolecules Hall, Andrew

76-77 S p. S41-S42
artikel
496 18F-Labelled inhibitors for targeting of IDH1 mutant gliomas Neumaier, Bernd

76-77 S p.
artikel
497 18F-labelled probes for non-invasive assessment of the IDH genotype in diffuse glioma Cologni, Roberta

76-77 S p. S17-S18
artikel
498 Fluoride mediated radiosynthesis of [11C]methyl esters Neelamegam, Ramesh

76-77 S p. S73-S74
artikel
499 Fluorinated PET imaging probes targeting fibroblast activation protein: radiolabeling and preclinical evaluation Elvas, Filipe

76-77 S p. S40-S41
artikel
500 Fluorine-18 Labeling of Neutrophil Elastase Inhibitors Holm, Linus Johansson

76-77 S p.
artikel
501 Fluorine-mediated desilylative Carbon-11 carboxylation of acylsilanes with [11C]CO2 for the radiosynthesis of [1-11C]α-keto acids Lee, Sanghee

76-77 S p.
artikel
502 Fluoroquinolone dithiocarbamate rhenium and technetium-99m complexes for potential infection imaging agents Shegani, Antonio

76-77 S p. S98
artikel
503 18F-microbubble for PET/US imaging: conception and in vivo imaging Ariztia, Julen

76-77 S p. S166-S167
artikel
504 [18F]MK-7246 for Positron Emission Tomography imaging of beta cells surface marker GRP44 Cheung, Pierre

76-77 S p.
artikel
505 Folate receptor targeted 64Cu/ICG-labeled layered double hydroxide nanoprobe for PET/CT and NIRF imaging Lee, Kyo Chul

76-77 S p.
artikel
506 Foldamers afford improved theranostics targeting cholecystokinin-2 receptor positive cancers Corlett, Alicia

76-77 S p. S16-S17
artikel
507 Formulation and evaluation of human clinical doses of 177Lu-labeled bisphosphonate amide of DOTA using lyophilized kits Chakraborty, Sudipta

76-77 S p. S99-S100
artikel
508 [18F]OXD-2314: A 4R-Tau PET Radiotracer with Improved Affinity and Brain Uptake Mason, Neale

76-77 S p.
artikel
509 From R&D scale to clinical trial: design of 64Cu-radiolabeled compound production for phase I process Drouin, Guillaume

76-77 S p. S141-S142
artikel
510 [18F]SuFEx-enabled access to an 18F-Labeled PSMA inhibitor intermediate Craig, Austin

76-77 S p. S81
artikel
511 [18F]Talazoparib: a novel potential PET imaging agent of PARP Muzzioli, Riccardo

76-77 S p. S7-S8
artikel
512 Fully automated and GMP-compliant synthesis of [18F]JK-PSMA-7 on a Trasis AllinOne module Ermert, Johannes

76-77 S p. S124
artikel
513 Fully automated and GMP-compliant synthesis of [18F]SynVesT-1 on a Trasis AllinOne module Ermert, Johannes

76-77 S p.
artikel
514 Fully automated macro- and microfluidic production and physiological animal biodistribution of [68Ga]Ga-citrate Ovdiichuk, Olga

76-77 S p. S134-S135
artikel
515 Fully Automated Production of [11C]ABP688, [11C]PS13, and [11C]PIB Using a TracerMaker Synthesis Module for Clinical Studies Hu, Bao

76-77 S p.
artikel
516 Fully automated purification of labelled antibody on PD-10 cartridges Maindron, Nicolas

76-77 S p. S131-S132
artikel
517 Fully automated radiochemical synthesis of [68Ga]FAPI-4 and its preclinical evaluation for clinical translation Sahu, Sudeep

76-77 S p. S211-S212
artikel
518 Fully Automated Radiosynthesis of 1-(2-[18F]Fluoroethyl)-L-Tryptophan ([18F]FETrp) Jiang, Huailei

76-77 S p.
artikel
519 Fully automated radiosynthesis of [18F]SMBT-1 for clinical use Tago, Tetsuro

76-77 S p.
artikel
520 Fully automated synthesis of [11C]nicotinamide for in vivo vitamin trafficking studies Shegani, Antonio

76-77 S p. S74-S75
artikel
521 Functionality of a co-culture kidney model: testing the renal barrier with [18F]fluorodeoxyglucose Sihver, Wiebke

76-77 S p.
artikel
522 Functionalization and radiolabeling of M13 bacteriophages for PET imaging Trommer, Johanna

76-77 S p.
artikel
523 Future prospects for SPECT imaging using the radiolanthanide terbium-155 — production and preclinical evaluation in tumor-bearing mice Müller, Cristina
2014
76-77 S p. e58-e65
nvt p.
artikel
524 [68Ga]Ga-DOTA-C-glycosyl-RGD: synthesis, in vitro evaluation and PET imaging Mengel, Emilien

76-77 S p. S203
artikel
525 [68Ga]Ga-DOTA-GIP1234 for PET imaging of glucose-dependent insulinotropic polypeptide receptor (GIPR) Khalil, Amina

76-77 S p.
artikel
526 [68Ga]Ga-HBED-CC-exendin-4: A new GLP1R targeting radiolabeled agent for pancreas β-cell and insulinoma imaging Li, Linlin

76-77 S p. S47-S48
artikel
527 [68Ga]Ga-HBED-CC-FAPI derivatives with improved radiolabeling and specific tumor uptake Li, Yuying

76-77 S p.
artikel
528 [68Ga]Ga-NODAGA-TriGalactan a new PET-tracer for imaging of the functional liver reserve Zierke, Maximilian

76-77 S p. S65
artikel
529 68Ga-labeled bivalent imaging agents targeting hypoxia and PSMA in tumors Liu, Tianqing

76-77 S p.
artikel
530 68Ga-labeled hypoxia and PSMA dual-targeting imaging agents Liu, Tianqing

76-77 S p.
artikel
531 68Ga-labeled Siderophores as Specific Radiotracers for Bacterial Infections Al-Bazaz, Silav

76-77 S p.
artikel
532 Ga-68-labelling of quinuclidine triazole-based compound Kanasuwan, Apinan

76-77 S p. S151-S152
artikel
533 Gallium-68 and Copper-64 radiolabelling of hepatotropic GBVA10-9 or CPB peptide derivatives for hepatocellular carcinoma imaging Brossard, Clarisse

76-77 S p. S153
artikel
534 68Ga-: 99mTc-labeled LHRH analog as new potential breast cancer imaging agents Alfaya, Lucia

76-77 S p. S49
artikel
535 68Ga-radiolabeling of hepatitis E virus-like nanoparticles and evaluation of their ex vivo biodistribution in mice Lambidis, Elisavet

76-77 S p. S106-S107
artikel
536 68Ga-radiolabeling reactions is a media of protic hydroxyalkylammonium ionic liquids based on diethanolammonium salts Antuganov, Dmitrii

76-77 S p. S96-S97
artikel
537 68Ge/68Ga-generator: a radionuclide source or an approved drug? Kvaternik, Herbert

76-77 S p. S100
artikel
538 Generation of 225Ac-DOTA-rituximab SPECT image from 64Cu-DOTA-rituximab PET image using unpaired image-to-image translation Kim, Kangsan

76-77 S p.
artikel
539 Genipin enhances 131I-rituximab induced cell cytotoxicity in lymphoma cells Vinod, Nagarajan

76-77 S p. S218
artikel
540 GLP-1R targeting 68Ga-exendin-4 derivatives with lower renal retention for insulinomas and β-cell mass imaging Liu, Tianqing

76-77 S p.
artikel
541 Glucose-albumin nanoplatform for treating renal ischemia-reperfusion injury using reactive oxygen species scavenging properties Park, Ji Yong

76-77 S p. S163
artikel
542 52gMn(II)-Labelled PSMA-ligands as bimodal PET/MR imaging probes Strecker, Jonas

76-77 S p. S157-S158
artikel
543 GMP complaint production and quality control of a [99mTc]Tc-DTPA-GSA wet kit formulation Denholt, Charlotte

76-77 S p.
artikel
544 GMP compliant high-yield radiosynthesis of [18F]AlF-PSMA-11 on the IBA Synthera®+ Platform Kersemans, Ken

76-77 S p.
artikel
545 GMP-compliant radiosynthesis of [18F]GP1 for the detection of thrombi Hugenberg, Verena

76-77 S p. S66
artikel
546 GMP-level production of radiometallated immune checkpoint inhibitor nivolumab: why and how? Suchy, Mojmir

76-77 S p. S61-S62
artikel
547 GMP Production of Copper-64 for antibody and nanobody radiolabeling: liquid vs solid target Hrynchak, Ivanna

76-77 S p.
artikel
548 Halogen bond in the context of At-211 radiolabeling: the case of [211At]N-succinimidyl-3-astatobenzoate Yssartier, Thibault

76-77 S p. S159-S160
artikel
549 Harnessing mushroom tyrosinase and the strain-promoted oxidation-controlled 1,2-quinone cycloaddition for the synthesis of site-specifically modified 89Zr-radioimmunoconjugates Rodriguez, Cindy

76-77 S p. S21-S22
artikel
550 Harnessing the theranostic potential of lead radioisotopes with sulphur-containing macrocycles Tosato, Marianna

76-77 S p. S158-S159
artikel
551 Harnessing 89Zr-PET to study the pulmonary clearance of microplastics in mice Keinaenen, Outi

76-77 S p. S55
artikel
552 Head-to-head comparison of [18F]Florastamin, [18F]FDG PET/CT, and 99mTc-HDP bone scintigraphy in patients with prostate cancer Lee, Inki

76-77 S p.
artikel
553 Head-to-head Comparison of [18F]Florbetazine ([18F]92) and [11C] PiB in Alzheimer’s Disease Li, Yuying

76-77 S p.
artikel
554 HER2-specific Affibody Molecule [99mTc]Tc-ZHER2:41071: phase I clinical trial Tolmachev, Vladimir

76-77 S p.
artikel
555 High affinity novel CXCR4 antagonists radiolabelled with copper-67 and gallium-68 for theragnostic applications Palmer, Max

76-77 S p. S59-S60
artikel
556 Highly automated solid target-based production of the emerging PET isotope cobalt-55 Gé, Lorraine

76-77 S p. S170
artikel
557 Highly modifiable cyclopentadienyl scaffolds for the rapid development of 99mTc radioprobes Lengacher, Rapahel

76-77 S p. S90
artikel
558 High radiochemical yield and molar activity 52gMn from electroplated chromium Barrett, Kendall

76-77 S p.
artikel
559 High-sensitivity ICP-MS – an alternative for in vitro and in vivo characterization of future radiometal-based theranostic candidates Wallimann, Rahel

76-77 S p. S42-S43
artikel
560 High yield GMP production of [18F]FE-PE2I, a radiotracer for in vivo PET imaging the dopamine transporter Moein, Mohammad Mahdi

76-77 S p. S132-S133
artikel
561 High yield lead-203 cyclotron production using a thallium-205 sealed solid target for diagnostic SPECT imaging Nelson, Bryce

76-77 S p. S12
artikel
562 [3H]OF-NB1 and [18F]OF-NB1: novel radioligands for the preclinical assessment of GluN1/2B targeting ligands Ahmed, Hazem

76-77 S p. S95-S96
artikel
563 Hyaluronic acid as a potential component of radiopharmaceutical with rhenium-188 for radiosynovectomy Malysheva, Anna

76-77 S p. S41
artikel
564 Hypoxia targeting lutetium-177 labeled gold nanoparticles for cancer theranostic application Mittal, Sweety

76-77 S p. S162-S163
artikel
565 Identification of non-competitive lead peptides for the development of PET tracers targeting PD-L1 Badenhorst, Melinda

76-77 S p.
artikel
566 Identification of (R)-[18F]YH134 as a promising reversible MAGL PET tracer and the impact of peripheral MAGL blockade on its brain uptake Mu, Linjing

76-77 S p.
artikel
567 Identifying Lymph Node Metastasis in High Grade Serous Ovarian Cancer Mouse Models via ImmunoPET Imaging Mack, Kyeara

76-77 S p.
artikel
568 Identifying new antigens on osteosarcoma and developing novel antibodies for radioimmunotherapy Prabaharan, Chandra

76-77 S p. S209-S210
artikel
569 Identifying Toxicity Mechanisms Associated with f-block Radiometals through Genome-wide Toxicogenomics Pallares, Roger Molto

76-77 S p.
artikel
570 Imaging acute and chronic stress using 2-[18F]FDG PET Krisch, Maximilian

76-77 S p.
artikel
571 Imaging characterization of National Cancer Institute patient derived xenograft models Drake, Christopher

76-77 S p. S185-S186
artikel
572 Imaging Lung Tumor Metastasis with 89Zr-DFO-Crizanlizumab Targeting P-selectin Majekodunmi, Olufolake

76-77 S p.
artikel
573 Imaging of AAV-mediated gene transfer in the brain using a novel PET reporter gene tracer Stotz, Sophie

76-77 S p. S106-S107
artikel
574 Imaging the Sirtuin 2 (SIRT2) protein - [18F]PF-SIRT, a novel positron emission tomography radioligand candidate Read, Cai

76-77 S p.
artikel
575 Imidazolium Salt-Mediated Radiofluorosulfurylation to Produce 18F-labeled Aryl Fluorosulfates Kim, Jaegwan

76-77 S p.
artikel
576 Immune mediated inflammation and perfusion in lungs of Covid-19 patients studied with [11C]GW457427 and [15O]water: a first-in-man pilot study Antoni, Gunnar

76-77 S p. S63
artikel
577 ImmunoPET imaging combined with focused ultrasound to study brain pharmacokinetic of 89Zr labeled anti-PD-L1 antibodies in a syngeneic murine model of glioblastoma Chevaleyre, Céline

76-77 S p. S181-S182
artikel
578 Implementation and optimisation of scandium-44 and manganese-52 production at King’s College London for preclinical research Nielsen, Karin Michaelsen

76-77 S p.
artikel
579 Implementation of iMiDEV, a new fully automated microfluidic platform for radiopharmaceutical production Ovdiichuk, Olga

76-77 S p. S60-S61
artikel
580 Improved droplet-based method for isotopic exchange labeling of trifluoroborate precursors Lisova, Ksenia

76-77 S p. S64-S65
artikel
581 Improved Purification of Cyclotron Produced [68Ga]GaCl3 for the Radiolabeling of Dotatate Wang, Ivan

76-77 S p.
artikel
582 Improved Synthesis and Automation of 2-(2,6-Difluoro-4-((2-(phenylsulfonamido)ethyl)thio)phenoxy)acetamide ([11C]K2) for Imaging AMPA Receptors Witek, Jason

76-77 S p.
artikel
583 Improved Synthesis of 3-[18F]Fluoro-p-Hydroxyphenethylguanidine ([18F]3F-PHPG) for Clinical Evaluation of Paraganglioma, Pheochromocytoma and Related Neuroendocrine Tumors Brooks, Allen

76-77 S p.
artikel
584 Improved synthesis of [18F]FPATPP via Ru-mediated 18F-Fluorination Rajala, Noora

76-77 S p. S135
artikel
585 Improvements in separation of antimony-119 from bulk tin target using a novel dibutyl ether resin Grundmane, Aivija

76-77 S p.
artikel
586 Improving PET imaging of urothelial carcinoma using manual synthesis of [68Ga]Ga-FAPI-46 and automated synthesis of [18F]AlF-FAPI-74 Toms, Johannes

76-77 S p.
artikel
587 Improving the quality of Ga radionuclides to achieve high radiolabeling yields Grundler, Pascal

76-77 S p. S45
artikel
588 111In/225Ac theranostic pretargeting of nodular colorectal peritoneal carcinomatosis: preclinical SPECT and autoradiography studies Chung, Sebastian

76-77 S p. S50
artikel
589 Indigenous preparation, quality control and evaluation of [90Y] Y-glass microspheres for treatment of liver cancer in India Chakraborty, Sudipta

76-77 S p. S180-S181
artikel
590 Influence of albumin binders on tumor uptake of [225Ac]Ac-mcp-PSMA radioconjugates Mamat, Constantin

76-77 S p. S29
artikel
591 Influence of pegylation and hapten location at the surface of radiolabelled liposomes on tumour immunotargeting using bispecific antibody Rauscher, A.
2014
76-77 S p. e66-e74
nvt p.
artikel
592 Influence of radiolysis on astatine-211 chemistry Ghalei, Mohammad

76-77 S p. S142
artikel
593 Influence of short PEG linkers on biodistribution of 225Ac-Macropa-YS5, an immunoconjugate for treating CD46 expressing cancer Bobba, Kondapa

76-77 S p. S53
artikel
594 Influence of the conjugation strategy on the stability of 89Zr-labeled immunoconjugates towards radiolysis Vizier, Romane

76-77 S p. S120
artikel
595 Influence of the conjugation strategy on the stability of 89Zr-labeled immunoconjugates towards radiolysis Vizier, Romane

76-77 S p. S97
artikel
596 Initial in vitro study of superparamagnetic iron oxide nanoparticles coated with 198AU for targeted radionuclide therapy and magnetic hyperthermia Zuk, Michal

76-77 S p. S87
artikel
597 Initial results of clinical phase 0 study on [68Ga]Ga-BOT5035/PET for the assessment of fibrosis activity Velikyan, Irina

76-77 S p. S68-S69
artikel
598 111In-labeled-anti-EphA2 antibody for SPECT imaging tracer targeting erythropoietin-producing hepatocellular receptor A2 Kimura, Hiroyuki

76-77 S p.
artikel
599 Inorganic ion molar absorptivity at higher energy UV wavelengths and how it affects high performance liquid chromatography results Arkins, Chase

76-77 S p.
artikel
600 In search of the HIV reservoir and a cure: translation of a CD30 imaging agent VanBrocklin, Henry

76-77 S p. S52
artikel
601 Intermediates en route to [99mTc]Tc-sestamibi: insights from HPLC and HPLC-MS do Mar Machado, Joana

76-77 S p. S36
artikel
602 INTERNATIONAL SCIENTIFIC PROGRAM COMMITTEE
76-77 S p.
artikel
603 Intramolecular Friedel-Crafts acylation of carbon-11 isocyanates enabling radiolabeling of [carbonyl-11C]DPQ Pichler, Verena

76-77 S p.
artikel
604 INTRODUCTION Cutler, Cathy S.

76-77 S p. S1-S2
artikel
605 Introduction of a polyethylene glycol linker enhances uptake of 64Cu-NOTA-conjugated lactam-cyclized alpha-MSH peptide in melanoma Qiao, Zheng

76-77 S p. S70
artikel
606 Introduction of terbium-161 into the clinics through its automated purification and the Good Manufacturing Practice compliant production of [161Tb]Tb-DOTA-LM3 Favaretto, Chiara

76-77 S p.
artikel
607 Introduction to this Abstract Supplement
76-77 S p. iii
artikel
608 Introduction to this Abstract Supplement
76-77 S p. ii
artikel
609 Investigating different chelators for a pretargeting approach with 203:212Pb- and 64:67Cu-labeled tetrazines Bauer, David

76-77 S p. S28-S29
artikel
610 Investigating the chemical scope of protein-ligation using photoactivatable chelates Earley, Daniel

76-77 S p. S114
artikel
611 Investigating the stereochemical requirements in the design of 68Ga-radiolabelled fibroblast activation protein inhibitors Flores, Jose Esteban

76-77 S p. S187
artikel
612 Investigating the theranostic potential of a novel MUC16-targeted antibody for ovarian cancer Mack, Kyeara

76-77 S p. S58-S59
artikel
613 Investigation into metabolic profile of [11C]Me-DPA Thomas, Keller

76-77 S p.
artikel
614 Investigation of cell surface murine CD68 as a pan-macrophage biomarker by immunoSPECT and optical imaging Roohani, Borna

76-77 S p.
artikel
615 Investigation of [18F]Regioisomer Formation in the Radiofluorination of Hypervalent Aryl Iodonium Salts and Ylides Zhao, Qunchao

76-77 S p.
artikel
616 Investigation of 68Ga/177Lu-labeled FAP-based inhibitor for diagnostic and therapeutic applications Imlimthan, Surachet

76-77 S p. S56-S57
artikel
617 Investigation of therapeutic effect, associated hypoxia and antioxidant signaling induced by copper-64 in colon carcinoma Niculae, Dana

76-77 S p.
artikel
618 Investigations of terbium-161 towards prostate cancer therapy using albumin-binding and standard PSMA ligands Müller, Cristina

76-77 S p. S27-S28
artikel
619 In vitro and in vivo evaluation of a 89Zr-labeled anti-TIP1 antibody Villas Boas, Cristian Wieczorek

76-77 S p. S37-S38
artikel
620 In vitro and in vivo evaluation of [11C]M4K2127 for PET imaging activin receptor-like kinase 2 Chasse, Melissa

76-77 S p.
artikel
621 In vitro and preliminary in vivo assessment of monocarboxylate transporter ligand as potential radiotracer for single photon emission computed tomography (SPECT) imaging of triple-negative breast cancer Schmitt, Sébastien

76-77 S p. S205
artikel
622 In-vitro binding assessment of soluble and insoluble tau protein variants with [18F]-AV1451 and [18F]-MK6240 Bansal, Aditya

76-77 S p. S99-S100
artikel
623 In vitro binding characteristic evaluation of radioconjugates targeting NRP-1 and: or NK1 receptor on glioma cancer model Halik, Pawel

76-77 S p. S53-S54
artikel
624 In vitro Characterizations of an S1PR1 Specific Radioligand [3H] CS1P1 in the Central Nervous System Jiang, Hao

76-77 S p. S30
artikel
625 In vitro evaluation of [18F]FDG-N3 cell uptake and intracellular SPAAC reactivity using Hoechst-DBCO Kovacs, Luciana

76-77 S p.
artikel
626 In vitro evaluation of 18F-fluorinated D-methionine and D-tyrosine derivatives as potential radiotracers for PET imaging of bacterial infection Betts, Helen

76-77 S p. S63-S64
artikel
627 In vitro evaluation of GPR17 radioligands as potential CNS stem cell imaging agents Kealey, Steven

76-77 S p. S38-S39
artikel
628 In Vitro Evaluation of [3H]PI-2620 and Structural Derivative in non-Alzheimer’s Tauopathies Varlow, Cassis

76-77 S p.
artikel
629 In vitro study of 177Lu-DOTA-Trastuzumab and 177Lu-DOTA-Pertuzumab for evaluation of binding affinity towards human cell lines with differential expression of HER-2 receptor Tawate, Megha

76-77 S p. S213
artikel
630 In vivo assessment of TNF-a expression by SPECT/CT antibod imaging using click chemistry in mice models of rheumatoid arthritis Yoo, Min Young

76-77 S p.
artikel
631 In vivo evaluation and optimization of [89Zr]Zr-DFO-NCS and [89Zr] Zr-(oxinate)4 for cell tracking Friberger, Ida

76-77 S p.
artikel
632 In vivo evaluation of carbon-11 labeled CRANAD-102 as a potential PET tracer for soluble species of amyloid-β species in the brain Staudt, Markus

76-77 S p. S105
artikel
633 In vivo evaluation of carbon-11 labeled 6,7-dimethoxy-1,2,3,4-tetrahydroinsoquinoline derivatives (11C-4-MPTHQ) for potential use as σ2R brain PET tracer Kim, Ho Young

76-77 S p. S40
artikel
634 In vivo evaluation of [18F]Fluoroethyl Fucose: a PET tracer for imaging and studying tumor senescence Cotton, Jonathan

76-77 S p.
artikel
635 In vivo PET imaging of 89Zr-labelled Natural Killer cell trafficking to solid tumour under the influence of a therapeutic antibody Pham, Truc

76-77 S p.
artikel
636 4-Iodophenyl-[18F]fluorosulfate as a versatile building block for Pd-catalyzed cross-coupling reactions Humpert, Swen

76-77 S p.
artikel
637 Isoindoline bridged [M(arene)2]+ ansa-[3]arenophanes of rhenium and 99mtechnetium Csucker, Joshua

76-77 S p. S4
artikel
638 Isolation of glioblastoma cancer stem cells by sedimentation field flow fractionation for the development of 3D models in supramolecular hydrogels Battu, Serge

76-77 S p. S160
artikel
639 Isotopic fluorine-18 radiolabelling of the anti-retroviral drug dolutegravir for pet imaging Caillé, Fabien

76-77 S p. S64
artikel
640 131I-urease nanomotors as potential radiotherapeutic agents for bladder cancer Gómez, María

76-77 S p.
artikel
641 133/135La-labeling of bleomycin and its initial radiopharmacological evaluation Nelson, Bryce

76-77 S p. S59
artikel
642 Lanatoside C enhances [225Ac]Ac-DOTA-rituximab induced cell cytotoxicity in lymphoma cells Nagarajan, Vinod

76-77 S p. S31
artikel
643 Lanatoside C enhances 131I-rituximab treatment in Raji lymphoma cells Song, Kanghyon

76-77 S p.
artikel
644 Large scale reliable production of [carboxyl-11C]acetate on the Synthra synthesizer. Solovyev, Dmitry

76-77 S p.
artikel
645 LC/MS coupled to radioactive detection for the chemical characterization of radiopharmaceuticals: identification of multiple intermediates en route to [99mTc]Tc-sestamibi do Mar Ferreira Machado, Joana

76-77 S p.
artikel
646 Leveraging an open science approach for PET radiotracer discovery: radiolabelling and preliminary neuroimaging of 11C-labelled activin receptor-like kinase 2 inhibitors Murrell, Emily

76-77 S p. S41
artikel
647 Longitudinal florzolotau (18F) PET study in a rat model of Alzheimer’s disease. Moreno, Oscar

76-77 S p.
artikel
648 Long term experience in [11C]UCB-J production in Turku PET Centre Krzyczmonik, Anna

76-77 S p. S126-S127
artikel
649 Low-dose targeted alpha therapy induces strong anti-tumor effectiveness in combination with immune checkpoint inhibitors Rodman, Samuel

76-77 S p.
artikel
650 177Lu-, 225Ac- and 111In-labelled nonadentate bispidine ligands: synthesis, radiolabelling experiments and stability assays Kopp, Ina

76-77 S p. S11
artikel
651 177Lu and 227Th Labeled 3,4,3-(LI-1,2-HOPO): characterization, optimized synthesis, biological distribution and dosimetry Sanders, Vanessa

76-77 S p. S25-S26
artikel
652 177LuIII- and 225AcIII-labelled bispidine-TATE conjugates: promising candidates for targeting neuroendocrine tumours Kubeil, Manja

76-77 S p. S68
artikel
653 177Lu-labeled Lys-urea-Aad-based PSMA-targeting radiotherapeutic agents with low uptake in mouse kidneys and salivary glands Kuo, Hsiou-Ting

76-77 S p. S32-S33
artikel
654 177Lu-labeling of on-resin clicked and cyclized HER2-targeting A9 peptide Sharma, Amit

76-77 S p. S47
artikel
655 [177Lu]Lu-DOTA-A9: A peptide probe targeting HER2 receptors Sharma, Amit

76-77 S p. S47
artikel
656 [177Lu]Lu-labeled gold nanoparticles as tumor hypoxia targeting platforms Mittal, Sweety

76-77 S p. S85-S86
artikel
657 [177Lu]Lu-labeled NaGdF4:Ho-Yb@m-SiO2 upconversion nanophosphors: synthesis and characterization as a potent theranostic probe Chakraborty, Sudipta

76-77 S p. S58-S59
artikel
658 [177Lu]Lu3+ labeling of Erlotinib analogues targeting EGFR-expressing cancers Jain, Akanksha

76-77 S p. S196
artikel
659 Making samrium-153 available for targeted radionuclide therapy Van de Voorde, Michiel

76-77 S p. S13
artikel
660 Management of legacy radioactive waste from [153Sm]Sm-lexidronam radiopharmaceutical Cusnir, Ruslan

76-77 S p. S65
artikel
661 Mannose Receptor (CD206) Targeting with Aluminum Fluoride-18 Labeled Mannosylated Dextran Andriana, Putri

76-77 S p.
artikel
662 Manual labeling, bio-distribution and administration of 177Lu-DOTATE: our long term insight at NORI Bokhari, Ayesha

76-77 S p. S122
artikel
663 Mass production of 64, 67Cu using accelerator-based fast neutrons Kawabata, Masako

76-77 S p.
artikel
664 Measurements of 186Re production cross section induced by deuterons on natW target at ARRONAX facility Guertin, Arnaud
2014
76-77 S p. e16-e18
nvt p.
artikel
665 Metabolic stability and tumor uptake improvements via an ABD-arm in [99mTc]Tc-DT10: first preclinical experiences in pancreatic cancer models Maina-Nock, Theodosia

76-77 S p. S17
artikel
666 Metabolites identification of the selective αvβ3 RGDechi chimeric peptides and their [99mTc][Tc(N)PNP]-derivatives Carpanese, Debora

76-77 S p. S44
artikel
667 Metallaphotoredox aryl and alkyl radiomethylation for PET ligand discovery Graham, Thomas

76-77 S p. S13
artikel
668 Method development for centralized clinical production of 177Lu-PNT2002 Dornan, Mark

76-77 S p.
artikel
669 mGluR5 exploration in healthy subject by [18F]FPEB Vercouillie, Johnny

76-77 S p. S109
artikel
670 Mild and direct 18F radiofluorination of tetrazines through sulfonium salt precursors Zhang, Wei

76-77 S p. S88-S89
artikel
671 Mild condition radiolabelling and in vivo stability of nanobody constructs with terbium-161 and terbium-155 Cassells, Irwin

76-77 S p. S53-S54
artikel
672 Mitochondria-targeted radiocomplexes for cancer theranostics Fernandes, Célia

76-77 S p. S51-S52
artikel
673 Modification of a commercial radiochemistry module for facile cGMP production of [18F]FET and [18F]FSPG Schulte, Michael

76-77 S p. S135-S136
artikel
674 Modification of the synthesis of 18F-labeled FC-119S for our automated synthesizer Kato, Koichi

76-77 S p.
artikel
675 Molecular imaging and radiopharmaceutical therapy of Multiple Myeloma targeting CD46 using 89Zr and 225Ac-YS5 Wadhwa, Anju

76-77 S p.
artikel
676 Molecular imaging for systemic treatment decisions in patients with cancer de Vries, Elisabeth GE

76-77 S p. S1
artikel
677 Molecular imaging of alcoholic liver disease with phosphodiesterase (PDE) 4B targeted [18F]PF-06445974 and positron emission tomography Shao, Tuo

76-77 S p. S18
artikel
678 Molecular imaging of cerebral dysfunction following liver failure with cannabinoid receptor type I targeted [18F]MK-9470 and positron emission tomography Shao, Tuo

76-77 S p. S53-S54
artikel
679 Molecular imaging of LPS induced neuroinflammation with P2x7 targeted [18F]JNJ-64413739 by positron emission tomography Chen, Jiahui

76-77 S p. S92-S93
artikel
680 Molecular imaging of murine liver fibrosis with sphingosine-1-phosphate receptor 1 targeted PET ligand Shao, Tuo

76-77 S p. S55-S56
artikel
681 Molecular imaging of Poly (ADP-ribose) polymerase for nnalcoholic steatohepatitis detection in preclinical models Jeppesen, Troels

76-77 S p. S67-S68
artikel
682 Molecular imaging of PSA using DARPin scaffolds Gut, Melanie

76-77 S p. S190-S191
artikel
683 Molecular Radiation Resistance Signature Induced by Alpha Emitters in Metastatic Castration-resistant Prostate Cancer: Early Clinical Outcome Prediction Amghar, Mariam

76-77 S p.
artikel
684 99mTc-labeled PSMA SPECT CT: a cost effective alternate of PET CT in diagnostic algorithm of prostate cancer Mir, Kahkashan

76-77 S p. S204
artikel
685 99mTc/Re tricarbonyl biguanide complexes for cancer theranostics Xiong, Chiyi

76-77 S p. S58
artikel
686 [99mTc]Tc-HYNIC-EcgDf21: a defensin short analog with potential application in infection foci imaging Gretter, Mariella Terán

76-77 S p. S63
artikel
687 [99mTc]Tc-(η6-pharm)2]+ synthesis with direct labelling of pharmaceuticals in water Battistin, Federica

76-77 S p. S3
artikel
688 [99mTc]Tc-PSMA-T4 a potential radiofarmaceutical for SPECT/CT imaging of metastatic prostate cancer Wojdowska, Wioletta

76-77 S p.
artikel
689 Multimodal radiobioconjugate - Trastuzumab-PEG-[198Au]AuNPs-PEG-DOX for targeted radionuclide therapy of HER2-positive cancers Żelechowska-Matysiak, Kinga

76-77 S p. S86
artikel
690 Nanoparticles as a Radionuclide Generator System for 225Ac/213Bi Diehl, George

76-77 S p.
artikel
691 Nanoscale microfluidic reactions: towards near-stoichiometric carbon-11 radiolabelling for PET Edgar, Fraser

76-77 S p. S69-S70
artikel
692 Nanosized crystalline vehicle for targeted radionuclide therapy Lemaître, Tom

76-77 S p.
artikel
693 Neuroimaging of p38 MAPK with [11C]SCIO-469 Enabled by Inhibition of P-glycoprotein Chasse, Melissa

76-77 S p.
artikel
694 New bicyclic somatostatin receptor agonists for imaging and therapy of neuroendocrine neoplasia Franchi, Sara

76-77 S p. S66-S67
artikel
695 New bifunctional linchpin for tandem peptide cyclization/ radiometal incorporation Yuen, Richard

76-77 S p. S120
artikel
696 New CD8 imaging agents to evaluate T-cell infiltration in tumors and predict response to immunotherapy Vivier, Delphine

76-77 S p. S218-S219
artikel
697 New extractant-impregnated iTLC-SG paper facilitates improved TLC analysis for Cu radiolabelled peptides Svedjehed, Johan

76-77 S p. S72
artikel
698 New H2dedpa derivatives designed for [67/68Ga]Ga3+ and [64Cu]Cu2+ radiopharmaceutical applications de Guadalupe Jaraquemada-Pelaez, Maria

76-77 S p. S149
artikel
699 NEw materials for conducting radiosynthesis of 18F-compounds Maindron, Nicolas

76-77 S p. S129-S130
artikel
700 New phase transfer agents for fluorine 18 radiolabelling Pelletier, Rémi

76-77 S p. S16-S17
artikel
701 New prospects for 89Zr-immuno-PET in brain applications: Alpha-synucleinopathies Wuensche, Thomas

76-77 S p.
artikel
702 New way to refine direct aromatic 18F-labeling of tetrazines Andersen, Ida

76-77 S p. S76
artikel
703 Next generation copper complexes for efficient production of radiolabeled aromatics Hoffmann, Chris

76-77 S p.
artikel
704 Next Generation of Radiopharmaceuticals via Engineering Antibody Derivatives Castilla, Susana Granados

76-77 S p.
artikel
705 Next generation therapeutic radiopharmaceuticals targeting cholecystokinin-2 receptor positive cancers Corlett, Alicia

76-77 S p. S16
artikel
706 Non-invasive assessment of fibrogenesis by PET imaging using a [Al18F]RESCA-Affibody molecule targeting PDGFRβ Wegrzyniak, Olivia

76-77 S p.
artikel
707 Non-invasive imaging of neutrophils in acute sepsis Wilske, Frida

76-77 S p.
artikel
708 Noninvasive imaging of STING expression in tumor microenvironment using radioiodinated small molecule Fang, Jianyang

76-77 S p. S52
artikel
709 Novel bifunctional [16]aneS4-derived chelators for soft radiometals Straathof, Natan

76-77 S p. S157
artikel
710 Novel boron-containing amino acid analogs for tumor positron tomography and boron neutron capture therapy Chen, Junyi

76-77 S p. S181
artikel
711 Novel FAPI tracers with albumin-binding properties for cancer imaging and therapy Meng, Lingxin

76-77 S p. S59
artikel
712 Novel folate radioconjugates: optimization of functional units to improve the tissue distribution profile Becker, Anna

76-77 S p. S11-S12
artikel
713 Novel 68Ga-labelled nanobody for imaging of platelet-derived growth factor receptor beta Velikyan, Irina

76-77 S p.
artikel
714 Novel [68Ga/177Lu]Ga/Lu-AAZTA-PSMA-093 as PSMA targeting agent for diagnosis and radiotherapy Liu, Tianqing

76-77 S p.
artikel
715 Novel [124I]ATRi VE-821 analogue PET tracer in mouse models for prostate cancer Artschwager, Raik

76-77 S p. S177
artikel
716 Novel 99mTc labelled proline isocyanide derivatives as potential tumour imaging agents Ruan, Qing

76-77 S p. S43-S44
artikel
717 Novel pyrazolethiazole derivatives as a promising new class of ligands for alpha-synuclein fibrils and potential PET tracers for the detection of α-synucleinopathies Bonanno, Federica

76-77 S p.
artikel
718 Novel pyrazolethiazole derivatives as new high affinity and selective ligands for alpha-synuclein fibrils as potential PET tracers for Parkinson’s disease Bonanno, Federica

76-77 S p. S90-S91
artikel
719 Novel Radiofluorination via Electrophilic Activation of Alkyl Phosphates/Phosphonate Zhang, Kaiqiang

76-77 S p.
artikel
720 Novel Universal Agent for Cutaneous Radioactive Decontamination Craig, Austin

76-77 S p.
artikel
721 Occupancy of Glucagon Like Peptide-1 receptor by Tirzepatide and SAR441255 measured with [68Ga]Ga-DO3A-exendin-4/PET in vivo. Khalil, Amina

76-77 S p.
artikel
722 O-[18F]fluoroalkylation of phenol derivatives with [18F] epifluorohydrin in the presence of t-Bu-P4 base Fujinaga, Masayuki

76-77 S p.
artikel
723 One batch multiple clinical doses production of [18F]FET with an home-built automated multipurpose [18F]-radiosynthesis module Zheng, Qi-Huang

76-77 S p. S139-S140
artikel
724 ‘One-fits-both’: searching a ligand for the chelation of theranostic mercury and silver radioisotopes Tosato, Marianna

76-77 S p. S11-S12
artikel
725 One-step automated radiosynthesis of N-succinimidyl-4-[18F]Fluorobenzoate ([18F]SFB) Nagachinta, Surasa

76-77 S p. S117
artikel
726 On the regiochemistry of the synthesis of 18F-labelled difluoroarenes via the copper mediated substitution of tin derivatives Stouse, Adrien

76-77 S p. S36-S37
artikel
727 Open-shell nanosensitizers for glutathione-responsive sonodynamic therapy of breast cancer Ni, Dalong

76-77 S p. S26-S27
artikel
728 Operation of a thorium-229/actinium-225 generator at Canadian Nuclear Laboratories Perron, Randy

76-77 S p.
artikel
729 Optical Imaging with a biological vector for diagnosis of oncologic diseases Thakur, Mathew

76-77 S p.
artikel
730 Optimal ‘hardness’ of non-macrocyclic chelators for [203Pb]Pb2+ radiopharmaceutical applications Ingham, Aidan

76-77 S p. S25
artikel
731 Optimisation of the radiosynthesis of [18F]FDG on MX cassette: application to the dual batch process on NEPTIS® platform Maindron, Nicolas

76-77 S p. S128-S129
artikel
732 Optimization of reaction conditions for the radiolabeling of DOTA and DOTA-peptide with 44m/44Sc and experimental evidence of the feasibility of an in vivo PET generator Huclier-Markai, S.
2014
76-77 S p. e36-e43
nvt p.
artikel
733 Optimization of reaction volumes and reagent amounts for the preparation of various 18F-radiolabelled radiotracers Maindron, Nicolas

76-77 S p. S130
artikel
734 Optimization of the automated radiosynthesis of an 18F-labeled tetrahydroquinoline derivative for brain HDAC6 imaging Tago, Tetsuro

76-77 S p.
artikel
735 Optimization of the routine production of the ketone body tracer (R)-[11C]3-hydroxybutyric acid Nielsen, Erik

76-77 S p. S23-S24
artikel
736 Optimized, automated and cGMP-compliant synthesis of the HER2 targeting [68Ga]Ga-ABY-025 tracer Jussing, Emma

76-77 S p.
artikel
737 Optimized pretargeting of [89Zr]Zr-DO3A-proteus radiohapten in rodent models of human colorectal cancer Le Roux, Alexandre

76-77 S p. S3-S4
artikel
738 Optimized QMA-elution enables direct aliphatic 18F-fluorination of highly reactive tetrazines for pretargeted imaging Bratteby, Klas

76-77 S p. S79-S80
artikel
739 Optimized quality control analysis for GMP production of the clinical 18F-labelled NET tracer [18F]SiTATE Kerminen, Edla

76-77 S p.
artikel
740 Optimized Radiosynthesis of Racemic 2-[18F]Fluoropropionic Acid for PET Imaging of Incipient Heart Failure Singh, Pradeep

76-77 S p.
artikel
741 Optimized synthesis of tri(hydroxypyridinone)-tetrazine and 68Ga-radiolabeling for bioorthogonal chemistry Centanni, Alessia

76-77 S p. S50-S51
artikel
742 Optimized synthesis of tris(hydroxypyridinone)-tetrazine and 68Ga radiolabeling for bioorthogonal chemistry Centanni, Alessia

76-77 S p. S148-S149
artikel
743 Optimizing 203Pb cyclotron production and availability: The ideal SPECT imaging theranostic partner for 212Pb targeted alpha therapy Nelson, Bryce

76-77 S p.
artikel
744 Optimizing the reaction conditions for the GMP production of [18F]ACI-12589, a promising candidate in the development as a PET tracer targeting α-synuclein Bratteby, Klas

76-77 S p. S87-S88
artikel
745 Organometallic cancer theranostics: incorporation of Re and 99mTc into the small molecule kinase inhibitor Opaganib® Lengacher, Raphael

76-77 S p. S55-S56
artikel
746 Organotin derivatives as versatile precursors for the radioiodination and radiofluorination of 1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid (TIC(OH)) analogues Maisonial-Besset, Aurélie

76-77 S p. S17
artikel
747 Original 18F-thiol prosthetic group for labeling of dehydroalanine-containing biologics Richard, Mylène

76-77 S p. S75
artikel
748 Our experiences working with the development module Neptis x Seed Ohlsson, Tomas

76-77 S p.
artikel
749 [15O]Water – a timeless challenge under GMP Ross, Tobias

76-77 S p.
artikel
750 Palladium-mediated synthesis of 11C-labelled acyl amidines and their cyclization to 11C-labelled 1,2,4-oxadiazoles from aryl halides and amidines Roslin, Sara

76-77 S p.
artikel
751 PAM and FUS-assisted local AAV gene delivery into the brain of Alzheimer’s disease murine models assessed by quantitative PET reporter gene Ajenjo, Javier

76-77 S p.
artikel
752 3p-C-NETA-TATE: a versatile somatostatin analogue for Al18F-labeled and therapeutic SSTR2 targeting radiopharmaceuticals Ahenkorah, Stephen

76-77 S p. S10-S11
artikel
753 PEGylated liposome encapsulating nido-carborane: boron neutron capture therapy (BNCT) and in vivo trafficking study in animal models Kim, Kyungwon

76-77 S p. S15
artikel
754 PEGylation modulation of peptides promotes PET detection of cancers Hu, Kuan

76-77 S p. S88-S89
artikel
755 Peptide turn mimics formed by the coordination of Tc:Re-tricarbonyl Oza, Dhvani

76-77 S p. S5
artikel
756 Perfluoroaryl azide staudinger reaction combined with sulfur [18F]Fluoride exchange click chemistry for live cell radiolabeling Biti, Anisa

76-77 S p. S78
artikel
757 Performance assessment of quantitative preclinical SPECT imaging with 155Tb and 161Tb Koniar, Helena

76-77 S p.
artikel
758 Performance evaluation of the IRIS XL-220 PET/CT system, a new camera dedicated to non-human primates Boisson, Frédéric

76-77 S p. S173
artikel
759 PET/CT Imaging of avb6 Integrin to Monitor Radiation-Induced Pulmonary Fibrosis Villas Boas, Cristian Wieczorek

76-77 S p.
artikel
760 PET/CT Imaging Reveals Enhanced Spleen Uptake After Humanization of an Annexin A1 Targeting Antibody Houson, Hailey

76-77 S p.
artikel
761 PET imaging and biological uptake of toxic diesel particulate matter in mice via different routes of exposure Park, Jung Eun

76-77 S p.
artikel
762 PET Imaging of [68Ga]Ga-NOTA-insulin in Alzheimer’s disease mouse model Pandey, Mukesh

76-77 S p.
artikel
763 PET imaging of lung inflammation in pig by neutrophil elastase inhibitor [11C]GW457427 Eriksson, Olof

76-77 S p. S65
artikel
764 PET imaging of neurotensin receptor-positive tumors with 68Ga-labeled antagonists: “the chelate makes again the difference” Renard, Emma

76-77 S p. S6-S7
artikel
765 PET Imaging of Neurotensin Targeting Peptide NOTA-NT-20.3 Using Cobalt-55, Copper-64 and Gallium-68 Houson, Hailey

76-77 S p.
artikel
766 PET imaging of PD-L1 expression in brain tumours Sharma, Gitanjali

76-77 S p.
artikel
767 PET imaging of PD-L1 overexpressing tumors with a 68Ga labeled D-dodecapeptide Hu, Kuan

76-77 S p. S2
artikel
768 Pharmacokinetic, dosimetry and antitumor efficacy of 64Cu/NOTA-terpyridine platinum, a potential radio-chemo-theranostic agent Khosravifarsani, Meysam

76-77 S p. S57
artikel
769 Pharmacokinetic preclinical evaluation of radioligation strategies impact on antibody fragment targeting PD-L1 Truillet, Charles

76-77 S p. S118-S119
artikel
770 Pharmacokinetics, Dosimetry and Therapeutic efficacy of [225Ac] Ac-DOTA-TDA-Lipiodol® in a murine cancer model: The importance of considering the actinium-225 in vivo generated decay daughters for accurate treatment dosing Josefsson, Anders

76-77 S p.
artikel
771 Phase I trial for SPECT imaging of GRPR expression in malignant tumors using [99mTc]Tc-maSSS-PEG2-RM26 prepared using one-pot labeling kit Orlova, Anna

76-77 S p.
artikel
772 Photoaffinity labeling for the site-specific bioconjugation of 89Zr-labeled radioimmunoconjugates Delaney, Samantha

76-77 S p. S17-S18
artikel
773 PhotoDynamicTherapy by Cerenkov luminescence induct by Gallium-68 on AGuIX@Terbium-porphyrin ultrasmall nanoparticle Collet, Charlotte

76-77 S p. S161
artikel
774 Photoredox-assisted 18F-radiodeoxyfluorination of diaryl ethers favors the more electron-rich aryl group Jiang, Meijuan

76-77 S p.
artikel
775 Polyacrylamide gel electrophoresis based method for investigation of metabolic stability of [68Ga]Ga-BOT5035 in vitro and in vivo Velikyan, Irina

76-77 S p.
artikel
776 Practical considerations on the production of copper radioisotopes from enriched liquid targets: a five years’ experience Fonseca, Alexandra

76-77 S p. S44-S45
artikel
777 Preclinical assessment of nanoparticles conjugated with 64Cu-DOTA-PEG-BBN targeting gastrin-releasing peptide receptors Niculae, Dana

76-77 S p. S14-S15
artikel
778 Preclinical characterization of [18F]FB-labeled single-domain antibodies for PET imaging of FAP-α or Folate-α overexpression in cancer Dierick, Herlinde

76-77 S p.
artikel
779 Preclinical development of CD133 targeted immunoPET probes Wyszatko, Kevin

76-77 S p. S19-S20
artikel
780 Preclinical development of [89Zr]Zr-DFO-Isatuximab as a novel immunoPET tracer for CD38-targeted imaging of multiple myeloma and lymphomas Alvarez, Natalia Herrero

76-77 S p. S192-S193
artikel
781 Preclinical evaluation of antisense-oligonucleotide (ASO) brain distribution using PET and SPECT imaging post intrathecal injection Rafidi, Hanine

76-77 S p.
artikel
782 Preclinical evaluation of ePSMA-DM1: a PSMA-targeting theranostic small molecule drug conjugate Seimbille, Yann

76-77 S p.
artikel
783 Preclinical evaluation of [18F]FBVM as a new potent PET tracer for vesicular acetylcholine transporter Vercouillie, Johnny

76-77 S p. S110
artikel
784 Preclinical Evaluation of [18F]F-[natLu]Lu-DOTA-rhCCK-18, the First 18F-Labeled Radiohybrid-Based Minigastrin Derivative with high Target Affinity and Tumor Accumulation Holzleitner, Nadine

76-77 S p.
artikel
785 Preclinical evaluation of [68Ga]Ga-BCY18469, a first-in-class EphA2-targeting radiotheranostic Bicyclic Peptide El Fakiri, Mohamed

76-77 S p.
artikel
786 Preclinical evaluation of GRPR-antagonists based on a highly stable variant for imaging of prostate cancer Kanellopoulos, Panagiotis

76-77 S p.
artikel
787 Preclinical evaluation of [111In]In-labeled GRPR-targeting DB15 mimics for potential theranostic use in prostate cancer Kanellopoulos, Panagiotis

76-77 S p.
artikel
788 Pre-clinical evaluation of lead-203 as an imaging surrogate for lead-212 radiopharmaceuticals Cagle, Brianna

76-77 S p. S22-S23
artikel
789 Preclinical evaluation of [155/161Tb]Tb-crown-TATE – a novel SPECT imaging agent targeting neuroendocrine tumors Wharton, Luke

76-77 S p.
artikel
790 Preclinical evaluation of [89Zr]Zr-DFO*-sacituzumab, a PET tracer for imaging of whole body TROP-2 expression as a potential selection tool for treatment with TROP-2 antibody drug conjugates (ADC) Bratteby, Klas

76-77 S p.
artikel
791 Preclinical evaluation of [89Zr]Zr-ramucirumab: the monoclonal antibody for imaging of VEGFR2 positive tumors Novy, Zbynek

76-77 S p. S56-S57
artikel
792 Preclinical PET imaging of GSK-3 in pancreatic cancer Boyle, Amanda

76-77 S p. S19
artikel
793 Preclinical validation of [18F]-FB-(Anti Human PD-L1) nanobody for PET imaging Dierick, Herlinde

76-77 S p. S141
artikel
794 Preface of the Workshop on Innovative Personalized Radioimmunotherapy (WIPR 2013) Huclier, Sandrine
2014
76-77 S p. e1-e6
nvt p.
artikel
795 Preliminary evaluation of a novel carbon-11 labeled brain-penetrant EGFR-TKI radiotracer for brain cancer imaging Guttormsen, Yngve

76-77 S p. S42-S43
artikel
796 Preliminary evaluation of 124I labeled virus receptor binding domain Li, Dan

76-77 S p. S50-S51
artikel
797 Preparation and cGMP-compliant production of the bombesin analogue [68Ga]Ga-NOTA-RM26 for first-in-human clinical study of gastrin-releasing peptide receptor expression in prostate cancer Jussing, Emma

76-77 S p. S197-S198
artikel
798 Preparation and characterization and radiolabelling of multivalent ligands towards positron emission tomography imaging of oligomeric forms of misfolded proteins involved in neurodegenerative diseases Thompson, Stephen

76-77 S p. S107-S108
artikel
799 Preparation and evaluation of an ADAM8-targeted 111In-labeled antibody for the detection of early pancreatic cancer Fuchigami, Takeshi

76-77 S p.
artikel
800 Preparation and multimodality imaging study of 64Cu labeled organic nanoparticles targeting fibroblasts activation protein (FAP) in U87MG model Wen, Li

76-77 S p. S164-S165
artikel
801 Preparation and preclinical evaluation of novel 18F-labeled FAP ligands Hoffmann, Chris

76-77 S p.
artikel
802 Preparation of a 18F-labeled COX-2 inhibitor via [18F]SuFEx reaction Craig, Austin

76-77 S p. S80
artikel
803 Preparation of a representative non-radioactive sterility sample during the preparation of a long-lived radiopharmaceutical Stuijt, Jeffrey

76-77 S p.
artikel
804 Preparation of 211At-labeled aromatic compounds from thioarylprecursors Maingueneau, Clémence

76-77 S p. S43-S44
artikel
805 Preparation of electrodeposited UO2 target for fission-99Mo production Shen, Yijia

76-77 S p. S103-S104
artikel
806 Preparation of 5-[18F],7-difluoro- and 5,7-[18F]difluorotryptophans Kolks, Niklas

76-77 S p. S35
artikel
807 Preparation of Infective Endocarditis Models and PET Imaging Studies Using [18F]FDG and Other Radiotracers Lim, Jeong Eun

76-77 S p.
artikel
808 Preparation of radiofluorinated tyrosine derivatives via 18F-SuFEx chemistry and their in vivo evaluation Walter, Nils

76-77 S p. S76
artikel
809 Preparation of radiolabeled sulfamoyl fluorides by SuFEx 18F/19F isotopic exchange and assessment of their in vivo stability Hoffmann, Chris

76-77 S p.
artikel
810 Preparation of titanium complexes for in vivo PET imaging Strecker, Jonas

76-77 S p. S8-S9
artikel
811 Preparing a 18F-labeled modification of a PD-L1 inhibitor via [18F] SuFEx reaction Craig, Austin

76-77 S p. S80-S81
artikel
812 Preparing Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist [18F]Ubrogepant to Enable Biodistribution Studies in Non-Human Primate Fan, Kuo-Hsien

76-77 S p.
artikel
813 Pressed chromium/sodium fluoride target for cyclotron production of manganese-52 Nielsen, Karin Michaelsen

76-77 S p. S102-S103
artikel
814 Pretargeted Alpha Therapy of Disseminated Cancer - Combining Click Chemistry and Astatine-211 Timperanza, Chiara

76-77 S p.
artikel
815 Pretargeted PET imaging of trans-cyclooctene functionalized spherical nucleic acids Auchynnikava, Tatsiana

76-77 S p.
artikel
816 Process validation of Ga-68 labelled FAPI-46 at HUS Diagnostic Center Koivula, Teija

76-77 S p. S143-S144
artikel
817 Production and application of the 203Pb/212Pb theranostic pair at TRIUMF McNeil, Brooke

76-77 S p. S95-S96
artikel
818 Production and characterization of high purity radioscandium isotopes, 43,47Sc, of clinical interest from proton bombardment on enriched [46,50Ti]TiO2 targets Cingoranelli, Shelbie

76-77 S p. S49-S50
artikel
819 Production and purification of the Auger emitters Lanthanum-135 and Erbium-165 Pedersen, Kristina

76-77 S p.
artikel
820 Production and radiochemical separation of terbium-155 from enriched gadolinium target material and its preliminary application in SPECT imaging Favaretto, Chiara

76-77 S p. S50-S51
artikel
821 Production of clinical amounts GMP compliant zirconium-89 from cyclotron liquid targets: towards global availability of 89Zr-based radiopharmaceuticals Silva, Magda

76-77 S p.
artikel
822 Production of emerging theranostic radionuclides at TRIUMF Radchenko, Valery

76-77 S p. S172
artikel
823 Production of [18F]fluoromannitol facilitated by solid phase flow chemistry toward PET Imaging of bacterial Infections Jouad, Kamal

76-77 S p.
artikel
824 Production of high-specific-activity erbium-169, ytterbium-175 and thulium-167 Talip, Zeynep

76-77 S p. S13-S14
artikel
825 Production of 117mSn using Sb alloy targetry Baumeister, Jakob

76-77 S p. S23-S24
artikel
826 Production of PET Radiopharmaceutical for Cholinergic Imaging Latter, Melissa

76-77 S p.
artikel
827 Production of Strontium-85 via deuteron-induced nuclear reactions on natural rubidium Tanzey, Sean

76-77 S p. S22
artikel
828 Production of 89Zr from cyclotron using yttrium foil: a new target design Pandey, Mukesh

76-77 S p. S103
artikel
829 Promising potential 68Ga-labeled small-molecular tracers for immune checkpoint ligand PD-L1 expression in tumor Lu, Jie

76-77 S p. S199
artikel
830 Proof-of-concept optimization of copper-mediated radiosynthesis of [18F]FBnTP using a novel automated robotic high-throughput droplet radiochemistry system Jones, Jason

76-77 S p.
artikel
831 Proof of principle: [18F]AlF radiolabelling using a droplet microreactor Lu, Yingqing

76-77 S p.
artikel
832 Protein 18F radiolabelling by Snap-Tag: synthesis and radiofluorination of O6-benzylguanine derivatives Ariztia, Julen

76-77 S p. S77
artikel
833 Quality assessment of cyclotron-produced 67Cu Brühlmann, Santiago

76-77 S p. S42
artikel
834 Quality control of 99mTc-radiopharmaceuticals: assessing our clinical practice do Mar Ferreira Machado, Joana

76-77 S p.
artikel
835 Quantification of radiotracer accumulation in a dynamic column-based 3D cell culture Pichler, Verena

76-77 S p. S14
artikel
836 Quantitation of a CB1R tracer [18F]FPATPP with radioLC/MS/MS Lahdenpohja, Salla

76-77 S p. S174
artikel
837 Quantitative Evaluation of a Novel PET Radioligand for the Monoacylglycerol Lipase (MAGL) in Non-Human Primates Gu, Jiwei

76-77 S p.
artikel
838 Quick determination of 90SR/90Y for application in nuclear medicine by counting gross-beta activity Tuan, Hoang

76-77 S p. S172
artikel
839 Radiation-induced DNA Damage and Repair in Targeted Radionuclide Therapies in Comparison to External Beam Radiation Winter, Ruth

76-77 S p.
artikel
840 Radioactive Isotopes for Cancer Radiotherapy Hoehr, Cornelia

76-77 S p. S2
artikel
841 Radiobioconjugates of 193m,195mPt nanoparticles for combined “chemo-Auger electron” therapy of hepatocellular carcinoma (HCC) and HER2+ breast and ovarian cancers Wawrowicz, Kamil

76-77 S p. S48
artikel
842 Radiochemical aspects of synthesis and analysis of [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T single-dose preparations Larenkov, Anton

76-77 S p. S152
artikel
843 Radiochemical formulation of 177Lu-DOTA-trastuzumab: using low specific activity 177LuCl3 Tawate, Megha

76-77 S p. S146
artikel
844 Radiochemical synthesis and automation of an 18F-radiolabelled oligonucleotide for PET imaging of miRNA-223 in relation to neuroinflammation Zientek, Simon

76-77 S p. S113-S114
artikel
845 Radiochemical synthesis of [18F]Fluoroanilines via flow reduction Wilde, Justin

76-77 S p. S139
artikel
846 Radiofluorination of Ruppert-Prakash reagent (Me3SiC[18F]F3) for syntheses of 18F-trifluoromethylated compounds Pees, Anna

76-77 S p. S23
artikel
847 Radiofluorination of Sterically Hindered Amides: Automation, Stability Studies, and Mechanism Wright, Jay

76-77 S p.
artikel
848 Radioiodinated and astatinated NHC rhodium complexes: Synthesis Rajerison, Holisoa
2014
76-77 S p. e23-e29
nvt p.
artikel
849 Radioiodination of galacto-bombesin using a residualizing prosthetic agent for imaging of gastrin-releasing peptide receptor Lim, Hwisoo

76-77 S p.
artikel
850 Radioiodination of prosthetic groups for disulphide rebridging Krzyczmonik, Anna

76-77 S p.
artikel
851 Radioisotope-loaded microbubbles for cancer imaging and therapy Gower-Fry, Kaley

76-77 S p. S149-S150
artikel
852 Radiolabeled chimeric interlukine-1 (IL-1) receptor antagonist for imaging tumor microenvironment of colorectal cancer Liu, Zhonglin

76-77 S p. S202
artikel
853 Radiolabeled gold nanoseeds containing substance P peptides: synthesis, characterization and evaluation in glioblastoma cells Raposinho, Paula

76-77 S p. S30
artikel
854 Radiolabeled Microbubbles as a Theranostic Modality in Nuclear Medicine Gower-Fry, Kaley

76-77 S p.
artikel
855 Radiolabeled peptidomimetic inhibitors of the VEGF:NRP-1 complex as diagnostic: therapeutic radiopharmaceuticals Masłowska, Katarzyna

76-77 S p. S56
artikel
856 Radiolabeled supramolecular coordination complexes targeted to somatostatin receptors Deiser, Sandra

76-77 S p. S73-S74
artikel
857 Radiolabeling and biological evaluation of functionalized spherical nucleic acids Auchynnikava, Tatsiana

76-77 S p. S39-S40
artikel
858 Radiolabeling and evaluation of cyclohexyl (5-(2-acetamidobenzo[d]thiazol-6-yl)-2-methylpyridin-3-yl) carbamate (PK68), a potent inhibitor for receptor interacting protein 1 kinase (RIPK1) Kumata, Katsushi

76-77 S p. S113
artikel
859 Radiolabeling and evaluation of 68Ga-DOTA-F56 peptide targeting vascular endothelial growth factor receptor Zhang, Qian

76-77 S p. S222
artikel
860 Radiolabeling and in vitro studies of scandium-44 with HOPO chelator for PET imaging Gajecki, Leah

76-77 S p. S52-S53
artikel
861 Radiolabeling and preclinical evaluation of a novel PET ligand for imaging phosphodiesterase (PDE) 4B Chen, Jiahui

76-77 S p. S91-S92
artikel
862 Radiolabeling of HER2 targeting single domain antibody with Tc-99m and Re-188 Altunay, Betül

76-77 S p. S6
artikel
863 Radiolabeling of HTE1PA: A new monopicolinate cyclam derivative for Cu-64 phenotypic imaging. In vitro and in vivo stability studies in mice Frindel, Mathieu
2014
76-77 S p. e49-e57
nvt p.
artikel
864 Radiolabeling of hyaluronan and hyaluronan-α vβ6-Binding Peptide for PET imaging Zhang, Hua

76-77 S p.
artikel
865 Radiolabeling of small molecules and peptides with therapeutic radionuclide Cu-67 for theranostic applications Pike, Susan

76-77 S p. S156
artikel
866 Radiolabeling of two different precursors of m-[211At] astatobenzylguanidine using 211At purified by wet extraction. Kang, Choong Mo

76-77 S p.
artikel
867 Radiolabelling of biomolecules with an original exo-maleimide prosthetic group Richard, Mylène

76-77 S p. S117-S118
artikel
868 Radiolabelling of DOTA-Kisspeptin with gallium-68 and lutetium-177 Kleynhans, Janke

76-77 S p. S143
artikel
869 Radiolabelling of small extracellular vesicles with gallium-68 Kunnas, Jonne

76-77 S p.
artikel
870 Radiometabolite structural confirmation of [11C]CS1P1, a promising radiotracer for imaging neuroinflammation of patients with Multiple Sclerosis Qiu, Lin

76-77 S p.
artikel
871 Radionuclide therapy with the second-generation Affibody molecule [188Re]Re-Z41071 improves survival in mice bearing human HER2-expressing xenografts Liu, Yongsheng

76-77 S p. S27
artikel
872 Radiopharmaceutical preparation and quality control of 225Ac-DOTAGA-IAC for tumor targeted alpha therapy (TAT) Pandey, Somit

76-77 S p. S144-S145
artikel
873 Radiopharmaceutical production and stability studies of 18F-rhPSMA-7.3 injection on a Siemens Explora GN Synthesis Module Haka, Michael

76-77 S p.
artikel
874 Radiopharmacological comparison of an Al18F- and 68Ga-labeled somatostatin agonist and antagonist in 2D and 3D models of BON-SSTR2 cells Sihver, Wiebke

76-77 S p.
artikel
875 Radiosynthesis and analysis of (S)-4-(3-[18F]fluoropropyl)-L-glutamic acid Brown, Gavin

76-77 S p.
artikel
876 Radiosynthesis and biological evaluation of a nicotinic acid hydroxamate derivative as a radioligand for HDAC6 PET imaging Tago, Tetsuro

76-77 S p. S107
artikel
877 Radiosynthesis and biological evaluation of 10-[11C] methoxy-berberine as a novel PET tracer for visualizing berberine metabolism and distribution in mice Zhang, Xiaojun

76-77 S p. S69
artikel
878 Radiosynthesis and biological evaluation of [18F]AG-120 as imaging agent for the detection of the mutant isocitrate dehydrogenase 1 in glioma by PET Toussaint, Magali

76-77 S p.
artikel
879 Radiosynthesis and biological evaluation of [18F]CooP: a brain-homing peptide for imaging glioblastomas using positron emission tomography Dillemuth, Pyry

76-77 S p. S18-S19
artikel
880 Radiosynthesis and biological evaluation of [18F]R91150, a selective 5-HT2A receptor antagonist for PET imaging Willmann, Michael

76-77 S p. S35-S36
artikel
881 Radiosynthesis and biological investigation of an 18F-labeled triazolopyridopyrazine-based inhibitor for imaging of the phosphodiesterase 2A enzyme (PDE2A) in brain Wenzel, Barbara

76-77 S p. S111
artikel
882 Radiosynthesis and Characterisation of [18F]antagomir-223: A Potential PET Radiotracer for Imaging Neuroinflammation Zientek, Simon

76-77 S p.
artikel
883 Radiosynthesis and evaluation of a new PET tracer for imaging of leucine-rich repeat kinase 2 Mori, Wakana

76-77 S p.
artikel
884 Radiosynthesis and Evaluation of a Novel 18F-Labeled Tracer for PET Imaging of Glycogen Synthase Kinase-3 (GSK-3) Li, Yinlong

76-77 S p.
artikel
885 Radiosynthesis and evaluation of [18F]SNFT-1 for imaging early tau deposition Harada, Ryuichi

76-77 S p.
artikel
886 Radiosynthesis and first preclinical evaluation of an 18F-radiolabelled ligand for cancer stem cells non-invasive PET imaging Toussaint, Magali

76-77 S p. S216
artikel
887 Radiosynthesis and in vitro comparison of [225Ac]Ac-DOTA-dhPzPEG4- and [225Ac]Ac-macropa-tzPEG3Sq-conjugated ch806, a tumour-specific anti-EGFR antibody, and preclinical evaluation in a murine glioma model Wichmann, Christian

76-77 S p. S14-S15
artikel
888 Radiosynthesis and in vitro evaluation of [99mTc]-labeled hyaluronic acid derivatives Sarasamkan, Jiradanai

76-77 S p. S156-S157
artikel
889 Radiosynthesis and preclinical biodistribution of a carbon-11-labelled STING agonist Hill, James

76-77 S p. S193
artikel
890 Radiosynthesis and preclinical evaluation of [11C]mitragynine isotopomers in rodents Seo, Jinpyo

76-77 S p.
artikel
891 Radiosynthesis and Preliminary Evaluation of a 18F-Labeled PET Tracer Targeting CYP1B1 Li, Yuying

76-77 S p.
artikel
892 Radiosynthesis and preliminary evaluation of an 18F-labeled diarylpyrrole-based PET tracer targeting COX-2 Li, Yuying

76-77 S p.
artikel
893 Radiosynthesis and preliminary evaluation of a novel PET probe for neuronal complement C3 activation imagingRadiosynthesis and preliminary evaluation of a novel PET probe for neuronal complement C3 activation imaging Suzuki, Chie

76-77 S p.
artikel
894 Radiosynthesis, in vitro and in vivo evaluation of [18F]Z-3540 for imaging 4R-tauopathies Lindberg, Anton

76-77 S p.
artikel
895 Radiosynthesis, in vitro and in vivo evaluations of [3H]/[18F]CBD-2115 as first in class radiotracers for imaging 4R-tauopathies Lindberg, Anton

76-77 S p. S9-S10
artikel
896 Radiosynthesis of [11C]EHT1610, a potential radioligand for quantification of cerebral DYRK1A by PET imaging POUTREL, Pauline

76-77 S p. S95
artikel
897 Radiosynthesis of 6-(2-cyclobutyl-5-(methyl-11C)-3H-imidazo[4,5-b]pyridin-3-yl)benzo[d]thiazol-2(3H)-one and (2-cyclobutyl-3-(1H-indazol-5-yl)-5-[11C]methyl-3H-imidazo[4,5-b]pyridine for imaging γ-8 dependent transmembrane AMPA receptor regulatory protein Yu, Qingzhen

76-77 S p. S97-S98
artikel
898 Radiosynthesis of D-[1-11C]alanine and D-[3-11C]alanine isotopomers Rabbitt, Sarah

76-77 S p.
artikel
899 Radiosynthesis of [18F]AmBF3-Tyr3-Octreotides with Tetrazine Ligation Based on the Inverse Electron-Demand Diels–Alder Reaction: Rapid, Catalyst-free and Mild Conversion of 1,4-Dihydropyridazines to Pyridazines Otaru, Sofia

76-77 S p.
artikel
900 Radiosynthesis of [18F]2- and [18F]4-fluoro[1,3]-pyrimidines Kumar, Dileep

76-77 S p. S82-S83
artikel
901 Radiosynthesis of [18F]fluoroadenosine derivative : a new imaging agent for HSP70 Ghosh, Pradip

76-77 S p. S72-S73
artikel
902 Radiosynthesis of [18F]FP-CIT using azetidinium salt precursor and evaluation of radiochemical purity and stability Kim, Dong Hyun

76-77 S p. S126
artikel
903 Radiosynthesis of 18F labelled D-amino acid tracers and their use for bacteria imaging Sorlin, Alexandre

76-77 S p. S68
artikel
904 Radiosynthesis of [18F]talazoparib and biodistribution study in PC3 prostate tumor mice Zhou, Dong

76-77 S p. S45
artikel
905 Radiosynthesis of [18F]VU6010572 as a PET radiotracer for imaging metabotropic glutamate receptor 3 (mGluR3) Rong, Jian

76-77 S p. S100-S101
artikel
906 Radiosynthesis of new PET tracer targeting macrophage mannose receptor Andriana, Putri

76-77 S p. S62-S63
artikel
907 Radiosynthesis of novel PET tracers for α-synuclein imaging Hoang, Anh

76-77 S p. S96
artikel
908 Rapid and Efficient Syntheses of [11C]Trifluoroethoxy Heteroarenes with a Novel 11C-Labeling Synthon, [11C]CF3CH2OK Zhao, Qunchao

76-77 S p.
artikel
909 Rapid and precise quantification of radiochemical yields by analytical HPLC with post column injection Humpert, Swen

76-77 S p.
artikel
910 Rapid copper-mediated radiosynthesis optimization for a novel monoacylglycerol lipase PET tracer on a high-throughput microdroplet radiochemistry platform Lu, Yingqing

76-77 S p.
artikel
911 223Ra-radiolabeling: predicting stability using molecular modelling Mohaman, Hamissou

76-77 S p. S154-S155
artikel
912 64 reactions in an hour using an automated, robotic high-throughput radiochemistry optimization platform Jones, Jason

76-77 S p. S59
artikel
913 Real-time tracking of micro- and nanoplastics in mice after pulmonary exposure Keinänen, Outi

76-77 S p.
artikel
914 Recovery and purification of Zn-68 after cyclotron irradiation and Ga-68 recovery Dunling, Eleanor

76-77 S p. S43-S44
artikel
915 Reducing protodeboronation using a novel boronic ester in the late-stage copper-mediated radiofluorination Jaworski, Carolin

76-77 S p. S46-S47
artikel
916 Reducing the renal retention of 111In-labelled fibronectin-binding peptides through brush border-enzyme sensitive cleavable linkers Valpreda, Giulia

76-77 S p. S34-S35
artikel
917 Reduction of pertechnetate by chemical and photochemical approaches and incorporation of Tc(IV) into titanium dioxide for wasteform development Salcedo, Ramsey

76-77 S p. S7
artikel
918 Reductive N-11C-methylation of anilines in dimethyl sulfoxide using in situ generated [11C]formaldehyde and 2-methylpyridine-borane Zhang, Ming-Rong

76-77 S p.
artikel
919 Re/99mTc complexes of 1,8-naphthalimide with varying linkers as dual-modality imaging agents Prabhu, Priyanka Jagadeesa

76-77 S p. S41-S42
artikel
920 Replacing high-performance liquid chromatography (HPLC) with high-resolution thin layer chromatography (TLC) for rapid radiopharmaceutical analysis Holloway, Travis

76-77 S p. S63
artikel
921 Reports on the advancements of organotrifluoroborates and their use in PET imaging Lozada, Jerome

76-77 S p.
artikel
922 Rhenium and technetium complexes in extremely low oxidation states Salsi, Federico

76-77 S p. S3-S4
artikel
923 Same-day solid target productions of clinically relevant quantities of 89Zr, 61Cu, and 68Ga by a single operator using a single chemistry module Svedjehed, Johan

76-77 S p.
artikel
924 Scale-up and optimisation of 199Au production from natPt0 and successful 199Au-labelling of bis-pyridine Rosecker, Veronika

76-77 S p.
artikel
925 Scale up production and purification of high specific activity lead-203 (203Pb) Saini, Shefali

76-77 S p.
artikel
926 Scandium-47 and lutetium-177 radiolabelling and stability studies of 1st and 2nd generation DOTA-triphenylphosphonium ligands – potential radionuclide theranostics for treatment of glioblastoma multi-forme Wyatt, Naomi

76-77 S p. S93-S94
artikel
927 Scandium exopolysaccharide complexes: evaluation of antiproliferative properties of on several cancer cell lines Munoz-Garcia, Javier

76-77 S p. S195-S196
artikel
928 Scandium(III) and macrocyclic cavity of DOTA-like ligands: implications for design of chelators for scandium radioisotopes Urbanovsky, Peter

76-77 S p. S68
artikel
929 (S)-2-(3-(carboxymethyl)ureido)-3-((2-hydroxy-3,4-dioxocyclobut-1-en-1-yl)amino)propanoic Acid as a Novel PSMA Targeting Scaffold for Prostate Cancer Imaging Liu, Tianqing

76-77 S p.
artikel
930 SCIFI: exciting BODIPY compounds with 89Zr-generated Cerenkov radiation Gristwood, Katie

76-77 S p. S167
artikel
931 Separation of cyclotron-produced cobalt-55/58 m from iron targets using cation exchange chromatography Lin, Wilson

76-77 S p.
artikel
932 Short PEG linkers considerably reduce background noise in immuno-PET tumor imaging Nam, Bora

76-77 S p. S207
artikel
933 Silicon-based Fluoride Acceptor (SiFA) on solid supports: a new versatile tool for 18F-fluorination of peptides and biological structures Steffann, Marine

76-77 S p. S87
artikel
934 Simple and quick indirect radioiodination to antibody without HPLC purification using fluorous solid-phase extraction and click reaction Im, Changkeun

76-77 S p. S125-S126
artikel
935 Simple and rapid automated synthesis of L-[11C]glutamine Fujinaga, Masayuki

76-77 S p. S124-S125
artikel
936 Simple method for the production of [11C]phosgene Krzyczmonik, Anna

76-77 S p. S72-S73
artikel
937 Site-selective 18F-labelling of octreotide via disulfide rebridging Richard, Mylène

76-77 S p. S86
artikel
938 Site-selective labelling of biomolecules via disulfide rebridging Richard, Mylène

76-77 S p. S4
artikel
939 Site-specifically THP-functionalized hPD-L1 single-domain antibody: preliminary data toward kit development Dierick, Herlinde

76-77 S p.
artikel
940 Site-specific [68Ga]Ga radiolabelling of antibodies through methionine conjugation Chi Yue, Thomas Tin

76-77 S p.
artikel
941 Site-specific radiofluorination of peptides via chemoselective S-arylation with 4-[18F]Fluoroiodobenzene Francis, Felix

76-77 S p. S116
artikel
942 Site-specific radiolabeling of an anti-HER2 single domain antibody fragment with an 211At-labeled prosthetic agent: preliminary evaluation of a potential targeted α-particle therapeutic Feng, Yutian

76-77 S p. S32
artikel
943 Site-specific 89Zr-labeling of a VHH construct as a half-life extending building block for PET and TRNT applications Leekens, Simon

76-77 S p.
artikel
944 Small-molecule antagonist radiotracers for positron emission tomography imaging of the mu opioid receptor. Plakas, Konstantinos

76-77 S p.
artikel
945 Small molecule-based angiogenic radiotracer for early detection and progression management of pulmonary arterial hypertension Yang, Zhen

76-77 S p. S67
artikel
946 Solid phase radiosynthesis of an 18F labeled olaparib derivative for PET imaging of PARP expression Zhou, Dong

76-77 S p. S222
artikel
947 Solid polyamine adsorbents for [11C]CO2 capture, purification, and radiosynthesis Chasse, Melissa

76-77 S p. S23
artikel
948 Sortase mediated conjugation and 89Zr-radiolabelling of the HER2 neu targeting G3-DARPin for in vivo PET imaging in BT-474-xenografts Fay, Rachael

76-77 S p. S89-S90
artikel
949 SPAAC incorporation of fluorine into FC131 analogues towards discovery of CXCR4 radiopharmaceuticals Mason, Julia

76-77 S p. S202-S203
artikel
950 Specific imaging of bacterial infections with 18F-labeled maltotriose ([18F]AAX90) Landau, Felicitas

76-77 S p. S8
artikel
951 Stabilization of 68Ga-labeled [Thz14]Bombesin(7–14) analogue for imaging gastrin-releasing peptide receptor expression with positron emission tomography Wang, Lei

76-77 S p.
artikel
952 StarPEG Nanocarriers for Prostate Cancer Imaging and Drug Delivery Meher, Niranjan

76-77 S p.
artikel
953 StarPEG Nanocarriers for PSMA Targeted Radioligand Imaging and Therapy Bidkar, Anil

76-77 S p.
artikel
954 Structure-activity relationship of pyrazol-4-yl-pyridine derivatives for imaging the muscarinic acetylcholine receptor M4 Haider, Ahmed

76-77 S p. S25
artikel
955 Structure-activity relationship study of peptide Gastramide-01 (GA-01), a potent binder of cholecystokinin-2 (CCK-2) receptor and theranostic candidate Rahimi, Marwa

76-77 S p. S107
artikel
956 Studies of [89Zr]ZrDFO*-Labeled Human Serum Albumin Applying Different Cysteine Bioconjugation Chemistry Kronberger, Julia

76-77 S p.
artikel
957 Studies on the novel scandium-47 labelled PSMA inhibitor targeting ligand Wojdowska, Wioletta

76-77 S p. S102
artikel
958 Studying the effect of structural modification of porphyrin derivatives on tumor uptake: Is lipophilicity the sole criterion? Guleria, Mohini

76-77 S p. S45-S46
artikel
959 Study of radiolabeled hepatotropic peptide derivatives for the diagnosis and treatment of hepatocellular carcinoma Nahas, Hanadi

76-77 S p. S41
artikel
960 Study of radiolabeled nanoplastics: synthesis and in vitro stability evaluation of Cu-64 and Lu-177 labeled polypropylene (PP) Kim, Heejung

76-77 S p.
artikel
961 Subtype-selective vasopressin 1A receptor imaging by positron emission tomography Haider, Ahmed

76-77 S p. S58
artikel
962 Supramolecular chemistry in the synthesis of radiopharmaceuticals d’Orchymont, Faustine

76-77 S p. S34
artikel
963 Survey of the use of yttrium-90 in selective radiotherapy for primary liver cancer treatment Tuan, Hoang

76-77 S p. S48
artikel
964 Syntheses and biological evaluation of two F-18 radiotracers for imaging MLKL in the brain Huang, Tianyu

76-77 S p.
artikel
965 Synthesis and Astatine Labeling of a bis-iminobiotin derivative with enhanced plasma stability Washiyama, Kohshin

76-77 S p. S121
artikel
966 Synthesis and bioevaluation of a novel SPECT agent targeting breast cancer estrogen receptor Lin, Xiaoru

76-77 S p. S53
artikel
967 Synthesis and biological evaluation of a novel radioligand [11C] BIO-1790735 for detection of O-GlcNAcase (OGA) enzyme activity Nag, Sangram

76-77 S p. S26
artikel
968 Synthesis and biological evaluation of 1-[2-(cyclopentadienyltr icarbonyltechnetium-99m)-N-vanillyferrocenecarboxamide for tumor imaging Dallegi, Tesnim

76-77 S p. S51
artikel
969 Synthesis and characterization of new hydrophilic trithiol chelates and their radioarsenic complexes Ma, Li

76-77 S p. S30
artikel
970 Synthesis and characterization of novel enrofloxacin derivatives and their rhenium and technetium-99m tricarbonyl complexes as potential therapeutic or diagnostic agents Tzovas, Georgios

76-77 S p. S99
artikel
971 Synthesis and Characterization of Radio-Halogenated Talazoparib Analogues for Radioligand Therapy Applications Muzzioli, Riccardo

76-77 S p.
artikel
972 Synthesis and evaluation of a bivalent radiohapten for DOTA-based pretargeted radioimmunotherapy Veach, Darren

76-77 S p. S61-S62
artikel
973 Synthesis and evaluation of a fluorinated PET imaging probe targeting fibroblast activation protein (FAP) Filippi, Nicolò

76-77 S p.
artikel
974 Synthesis and evaluation of a [68Ga]Ga-labeled water soluble porphyrin as a tumor targeting theranostic agent: in-vitro and in-vivo studies Kumar, Naveen

76-77 S p. S183-S184
artikel
975 Synthesis and evaluation of a 68Ga-labeled PSMA-targeting tracer with a rigid linker to reduce kidney and salivary gland uptake Kuo, Hsiou-Ting

76-77 S p.
artikel
976 Synthesis and evaluation of an 18F labeled conformationally flexible benzamide analog ([18F]Fluoroethyl HY-2-92) for D3R PET Studies Kim, Ho Young

76-77 S p. S96-S97
artikel
977 Synthesis and evaluation of an 18F-labeled PSMA-targeting tracer for imaging prostate cancer with positron emission tomography Lu, Kelly

76-77 S p.
artikel
978 Synthesis and evaluation of a novel PET tracer for imaging monoamine oxidase-B Fujinaga, Masayuki

76-77 S p.
artikel
979 Synthesis and evaluation of a radioligand for PET imaging of hepsin Park, Ji-Hun

76-77 S p. S183
artikel
980 Synthesis and evaluation of 18F-labeled tracer candidates targeting the Abelson non-receptor tyrosine kinase in Parkinson’s disease Stéen, E. Johanna

76-77 S p. S27
artikel
981 Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for amyloid PET-imaging Schlein, Eva

76-77 S p. S101-S102
artikel
982 Synthesis and evaluation of 68Ga-labeled [Leu13ψThz14] Bombesin(7-14) analogues for imaging gastrin-releasing peptide receptor expression with positron emission tomography Wang, Lei

76-77 S p. S219
artikel
983 Synthesis and Evaluation of Modified NOTA Chelators Labeled with [99mTc]Tc/Re-Tricarbonyl for Potential Theranostic Agent Development Kamboj, Ritin

76-77 S p.
artikel
984 Synthesis and evaluation of novel 18F-labeled indole-based derivatives as sigma-2 receptor radioligands for imaging the proliferative status of tumors Zhang, Ying

76-77 S p. S197
artikel
985 Synthesis and evaluation of novel PET ligands for imaging Orexin2 receptor (OX2R) Rong, Jian

76-77 S p. S101
artikel
986 Synthesis and evaluation of PET ligands for monoacylglycerol lipase in brain Mori, Wakana

76-77 S p. S99
artikel
987 Synthesis and evaluation of [186Re]Re(CO)3-p-NCS-benzyl-NODAGA-Ser2-RM2 for future development as a GRPR-antagonist for targeting prostate cancer Hoerres, Rebecca

76-77 S p. S90-S91
artikel
988 Synthesis and in vitro and in vivo evaluation of a new 64Cu-semicarbazone complex: potential theranostic radiopharmaceutical for hypoxic tumor Aljammaz, Ibrahim

76-77 S p. S52
artikel
989 Synthesis and in vitro stability evaluation of Cu-64 labeled branched polyethyleneimine (BPEI) Choi, Se-hwan

76-77 S p.
artikel
990 Synthesis and in vitro stability evaluation of Cu-64 labeled linear polyethylenimine (LPEI) as a preliminary study Jang, Jaebaek

76-77 S p.
artikel
991 Synthesis and in vivo characterization of a heterobivalent radiotracer targeting PSMA and GRPR for prostate cancer imaging Bailly, Thibaud

76-77 S p. S177-S178
artikel
992 Synthesis and optimization of radiotracers targeting P2Y12 receptors for positron emission tomography imaging of neuroinflammation Pincemail, Eugénie

76-77 S p. S99-S100
artikel
993 Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor Högnäsbacka, Antonia

76-77 S p. S38-S39
artikel
994 Synthesis and preclinical evaluation of [18F]DASA-10 a second generation PKM2 specific radiotracer Beinat, Corinne

76-77 S p.
artikel
995 Synthesis and preclinical evaluation of [methylpiperazine-11C]brigatinib as a PET imaging agent for mutated EGFR and ALK positive tumors Högnäsbacka, Antonia

76-77 S p. S51-S52
artikel
996 Synthesis and preclinical evaluation of 99mTc sandwich complexes targeting LAT1 and CRBN Sadeghi, Saman

76-77 S p. S32
artikel
997 Synthesis and preclinical evaluation of PD-L1 PET tracer [18F]FDHPA in mice Tong, Jie

76-77 S p. S214
artikel
998 Synthesis and Preclinical Evaluation of Three Novel 68Ga-labeled PSMA-FAP Heterodimeric Tracers for Imaging of Prostate Cancer Wang, Lei

76-77 S p.
artikel
999 Synthesis and preliminary evaluation of novel aminoimidazoline derivatives targeting the norepinephrine transporter Lu, Jie

76-77 S p. S199
artikel
1000 Synthesis and preliminary in-vitro studies of [99mTc][TcN(PNP)]-biphosphonates as new bone-radiopharmaceuticals. Carpanese, Debora

76-77 S p. S44-S45
artikel
                             1155 gevonden resultaten
 
   volgende >>
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland